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1 INTRODUCTION 
Considerable evidence suggests that depressive disorders and in particular 
persistent forms of depression are associated with the experience of childhood 
maltreatment (CM) (Bailer et al., 2014; Klein, Roniger, Schweiger, Spath, & 
Brodbeck, 2015; Rehan, Antfolk, Johansson, Jern, & Santtila, 2017; Riso, Miyatake, 
& Thase, 2002; Spinhoven et al., 2010; Teicher & Samson, 2013; Wiersma et al., 
2009). CM, that is, “all forms of physical, and/or emotional or sexual abuse, 
deprivation and neglect of children or commercial or other exploitation resulting in 
harm to the child’s health, survival, development or dignity in the context of a 
relationship of responsibility, trust or power” (World Health Organization, 2013, p.1) 
increases the risk to develop a persistent form of depression. Moreover, a history of 
CM has a negative effect on response and outcome of treatment for persistent 
depression (Nanni, Uher, & Danese, 2012).  
 Persistent forms of depression are prevalent (Keller & Shapiro, 1982; Kessler 
et al., 2005; Murphy & Byrne, 2012; Satyanarayana, Enns, Cox, & Sareen, 2009), 
particularly burdensome for patients as well as for society (Angst, Gamma, Rössler, 
Ajdacic, & Klein, 2009; Holzel, Harter, Reese, & Kriston, 2011; Satyanarayana et al., 
2009), and more difficult to treat than episodic depression (Cuijpers et al., 2010; 
Keller & Boland, 1998; Kocsis, 2003). 
According to McCullough (2000), CM is central to the aetiology of early onset 
persistent depression. He postulates that patients with a history of significant CM 
typically exhibit certain characteristics: Piagetian preoperational thinking, diminished 
insight into the interpersonal effects of one’s own behaviours, a lack of perceived 
agency which goes along with felt and expressed despair, and a submissive or 
hostile-submissive interpersonal behavioural style. McCullough (2000) argues that 
these features can impede the working relationship between patient and therapist - 
hereafter referred to as the alliance. He maintains, that persistently depressed 
patients necessitate a distinct personal therapeutic alliance which provides new 
relational experiences for patients. Thus, McCullough (2000) developed the first 
disorder-specific treatment for persistent depression called the Cognitive Behavioral 
Analysis System of Psychotherapy (CBASP). CBASP explicitly addresses the 
alliance between patients and therapists. It incorporates specific techniques, such as 
analyzing interpersonal situations as well as transference and countertransference 
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between patient and therapist, in order to help patients improve on their cognitive-
emotional processing, interpersonal skills and social deficits (Arnow, 2005; 
McCullough, 2000; 2012). 
There is reasonable evidence suggesting that CBASP is an effective treatment 
option for persistently depressed patients (e.g., Kriston, Wolff, Westphal, Hölzel, & 
Härter, 2014) and that alliance predicts outcome of treatment with CBASP (Arnow et 
al., 2013). Yet, little is known about how persistently depressed patients perceive the 
alliance over the course of treatment with CBASP. Furthermore, although it is 
assumed that patients’ experience of CM aggravates the alliance, it remains 
unknown how CBASP effects the alliance in patients with a history of CM. Given that 
the therapeutic alliance is considered one of the most important facilitators of 
therapeutic change (Wampold & Imel, 2015), an understanding of how CBASP 
influences the alliance, and how this effect is impacted by CM, appears necessary for 
both research and practice. 
This dissertation sought to address the described gap in the literature by 
means of two empirical studies: The first study examined the psychometric properties 
of the German Helping Alliance Questionnaire (HAQ; Bassler, Potratz, & 
Krauthauser, 1995). The second study applied the HAQ to investigate the patient-
rated alliance in a sample of persistently depressed patients who receive either 
CBASP or nonspecific supportive psychotherapy (SP), and who have experienced 
different degrees of CM. The studies will be embedded into introductory chapters on 
the theoretical background and a closing general discussion. Both studies have taken 
place within a clinical trial titled „A comparison of the Cognitive Behavioral Analysis 
System of Psychotherapy against supportive psychotherapy for early onset chronic 
depression“, which was registered on ClinicalTrials.com (NCT00970437) (Schramm, 
2015).  
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2 THEORETICAL BACKGROUND 
It was estimated that globally, depression is the fourth most burdensome disease and 
that by the year 2020 depression will rank second (Murray & Lopez, 1996; Ustun, 
Ayuso-Mateos, Chatterji, Mathers, & Murray, 2004). In Europe, Depression is among 
the most prevalent psychiatric disorders (Wittchen & Jacobi, 2005; Wittchen et al., 
2011). Its 12-month prevalence rate is estimated between 6-11% (Busch, Maske, 
Ryl, Schlack, & Hapke, 2013; Jacobi et al., 2015; Jacobi et al., 2004; Riolo, Nguyen, 
Greden, & King, 2005; Wittchen, Jacobi, Klose, & Ryl, 2010; Wittchen et al., 2011). 
Findings on lifetime prevalence are higher and vary between 11.6% and 19% (Busch 
et al., 2013; Jacobi et al., 2004; Wittchen et al., 2010). For patients, depression is 
associated with grave personal suffering, impaired social functioning, and an 
increased risk for comorbidities (e.g., Angst et al., 2009; Wittchen et al., 2010). On a 
societal level depression entails high illness-related cost, such as the cost for 
treatments or absenteeism from work (Andlin‐Sobocki, Jönsson, Wittchen, & Olesen, 
2005; Federal Statistical Office (Destatis), 2015; Friemel, Bernert, Angermeyer, & 
König, 2005; Kleine-Budde et al., 2013; Luppa, Heinrich, Angermeyer, König, & 
Riedel-Heller, 2007; Wittchen et al., 2010). 
Both the individual and the societal burden of depression is aggravated when 
the disorder is persistent, which it is for approximately 30% of cases (Angst et al., 
2009; Arnow & Constantino, 2003; Holzel et al., 2011; Kessler et al., 2005; Murphy & 
Byrne, 2012; Satyanarayana et al., 2009). What is more, persistent forms of 
depression are more difficult to treat than episodic depression (Cuijpers et al., 2010; 
Keller & Boland, 1998; Kocsis, 2003).  
In the following chapters, persistent depression will be defined and 
epidemiologically described. Following that, risk factors and models on the aetiology 
of persistent depression will be presented before giving an overview on treatment 
options and their efficacy. 
2.1 Definition  
According to Brakemeier, Schramm, & Hautzinger (2012), persistent depressive 
symptoms have been described in the literature in the context of personality 
disorders: renowned concepts like Kraepelin’s depressive temperament, Schneider’s 
depressive psychopathology, and Kernberg’s depressive-masochistic personality 
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disorder allude to what today is referred to as persistent depression. Akiskal’s 
introduction of the term dysthymia moved persistent depressive symptoms from the 
realm of personality disorders into the category of affective disorders (Brakemeier et 
al., 2012).  
Today, an internationally recognized definition of persistent depression is 
lacking. There is however consensus that persistent depression can take different 
forms and endures at least 2 years with no period of full remission lasting 2 months 
or longer (Berger, van Calker, Brakemeier, & Schramm, 2015; Gelenberg, Kocsis, 
McCullough, Ninan, & Thase, 2006). In terms of persistent depression, the 
International Classification of Disease, 10th edition (ICD-10; World Health 
Organization, 2004) only addresses and specifies diagnostic criteria for dysthymia 
which is a milder form of depression. Dysthymia is defined as a prolonged state of 
depressed mood which lasts at least 2 years and in which episodes of depressive 
symptoms do not meet the diagnostic criteria for recurrent depressive disorder. The 
Diagnostic and Statistical Manual, 4th edition (DSM-IV; American Psychiatric 
Association, 2000) uses separate diagnostic categories for 2 forms of persistent 
depression: dysthymic disorder and major depressive episode, chronic type. 
Dysthymic disorder is defined as a relatively mild condition, which begins without a 
prior major depressive episode, presents with depressed mood and a minimum of 2 
additional depressive symptoms. The symptoms prevail for at least 2 years and 
persist without symptom free periods of more than 2 months. Major depressive 
episode, chronic type describes a more severe clinical condition in which a person 
experiences major depression, that is, depressed mood and/or loss of interest and at 
least 5 additional depressive symptoms, continuously for at least 2 years. 
In addition to these formally acknowledged and defined disorders other 
subtypes of persistent depression have been observed: Most patients with dysthymic 
disorder experience superimposed major depressive episodes (Klein, Shankman, & 
Rose, 2006). This comorbidity, while not formally recognized, is referred to as double 
depression (Klein, 2010). Patients who experience recurrent major depression with 
partial interepisode recovery for more than two years may also be regarded as 
suffering from persistent depression (Klein, 2010). 
The differentiation between the above categories of persistent depression 
could not be supported by studies on aetiology and treatment outcome, though. 
Rather, research findings indicated that persistent forms of depression share distinct 
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characteristics that are different from episodic depression independent of symptom 
severity (Klein, 2008, 2010). Hence, to arrive at more valid diagnostic classes, the 
recent Diagnostic and Statistical Manual, 5th edition (DSM-V; American Psychiatric 
Association, 2013), collapsed the DSM-IV diagnoses major depressive episode, 
chronic type and dysthymic disorder into the new category persistent depressive 
disorder. Diagnostic criteria for persistent depressive disorder are based on those for 
dysthymic disorder from DSM-IV. Furthermore, additional specifiers allow 
distinguishing between early and late onset as well as between 4 subtypes of 
persistent depression: 1) with pure dysthymic syndrome; 2) with persistent major 
depressive episode; 3) with intermittent major depressive episodes, with current 
episode, and 4) with intermittent major depressive episodes, without current episode 
(Figure 1). Throughout this dissertation, the term persistent depressive disorder or 
persistent depression will be used to refer to any form of persistent depression, if not 
otherwise specified. 
 
Figure 1. DSM-V persistent depressive disorder (adapted from Klein & Beltz, 2014, 
p. 13). 
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2.1.1 Epidemiology and course of persistent depression 
As mentioned in the introduction, depressive disorders are common and burdensome 
(e.g., Murray & Lopez, 1996; Ustun et al., 2004). It has been estimated that 22-36% 
of all outpatients are affected by dysthymic disorder (Klein & Santiago, 2003). 
Approximately 20% of patients suffering from depression meet the criteria for 
persistent depressive disorder (Arnow & Constantino, 2003; Gilmer et al., 2005; Klein 
& Santiago, 2003); about one third of cases with a lifetime diagnosis of depression 
have been affected by persistent depressive disorder (Murphy & Byrne, 2012). Most 
patients with persistent depression experience an early onset of the disorder, that is, 
before the age of 21 (e.g., Keller et al., 2000; Klein et al., 1999; Schramm et al., 
2015). For all forms of persistent depression 12-months prevalence rates range from 
0.5-4.5%; lifetime prevalence rates vary between 0.9-6.1% depending on study and 
type of persistent depression (Blanco et al., 2010; Jacobi et al., 2015; Kessler et al., 
2005; Murphy & Byrne, 2012; Riolo et al., 2005; Satyanarayana et al., 2009; Wittchen 
et al., 2010). Major depressive disorder, chronic type is comparatively seldom and 
has a 12-months/lifetime prevalence of 1.5% and 3.1% respectively (Blanco et al., 
2010). Prevalence rates are significantly higher for dysthymic disorder: 1.7-4.5% (12-
months prevalence) and 2.5-6.1% (lifetime prevalence) (Jacobi et al., 2015; Kessler 
et al., 2005; Riolo et al., 2005; Wittchen et al., 2010). Women are almost twice as 
often affected from persistent depression as men (Blanco et al., 2010). The 20 years 
cumulative incidence of persistent depression in a prospective study on a community 
sample was 5.7% (Angst et al., 2009). 
Studies on the course of persistent depression underscore the burden of the 
disease: In a 10-year observation of 431 patients with major depressive disorder, 
Mueller et al. (1996) found that 12.3% of patients remained continuously depressed 
for the first 5 years. Of the non-remitters, 38% recovered within the following 5 years 
of the study. Klein and colleagues published prospective studies on the naturalistic 
course (i.e., treatment was not controlled for) of persistent depression in 86 and 97 
outpatients with early onset dysthymic disorder (Klein, Schwartz, Rose, & Leader, 
2000; Klein et al., 2006). They found that after 5 years, 52.9% of patients had 
recovered but that 45.2% of them relapsed during the following observation period 
which on average lasted 23 months. 73.7% of patients who had no lifetime diagnosis 
of major depressive disorder before study begin, developed a major depressive 
episode during follow-up (Klein et al., 2000). In the 10-year follow-up study, 73.9% of 
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patients with early onset dysthymic disorder recovered within a medium time of 52 
months. Of the recovered patients, 71.4% experienced a relapse into another 
persistent depression. In comparison to patients with non-persistent depression, 
dysthymic patients showed a slower improvement in symptoms and indicated greater 
depressive symptoms after 10 years (Klein et al., 2006). Secondary analyses on the 
data from the 5-year prospective study (Klein et al., 2000) suggested that higher 
probabilities to recover were correlated with bipolar disorder in the family; lower rates 
of recovery were associated with persistent stress, comorbid anxiety disorder, and 
characteristics of dependent, obsessive-compulsive and depressive personality 
disorder. Poorer outcome at follow up with regards to depression severity was 
predicted by a positive family history of persistent depression, early adversity, lifetime 
diagnoses of anxiety or eating disorder, certain personality features, neuroticism and 
the experience of long-term strain (Hayden & Klein, 2001). Together these findings 
indicate that persistent depression has relatively low rates of spontaneous remission, 
high rates of relapse and increases the risk for future affective symptoms and 
disorders.  
2.1.2 Correlates of persistent depression 
Beyond the above findings on what influences the course of the disorder, research 
found that persistent depression causes forgone human capital (e.g., educational 
attainment or earnings), especially in female patients (Berndt et al., 2000). Persistent 
depression has been linked to several aspects of socioeconomic disadvantage, racial 
or ethnic minority group affiliation as well as a younger age of onset, a greater illness 
burden in general and a history of suicide attempts (Gilmer et al., 2005; Murphy & 
Byrne, 2012). 
 Persistent depression in general has been linked to more frequent medical 
and psychiatric comorbidities, more depressive episodes, increased disability and 
utilization of the health care system as well as to suicidality (Angst et al., 2009; 
Murphy & Byrne, 2012; Satyanarayana et al., 2009). In comparison to non-persistent 
depression, dysthymic disorder is associated with more severe depressive 
symptoms, a higher burden on the health care system, a lower level of functioning, 
and a greater probability to attempt suicide or to be hospitalized (Klein et al., 2000; 
McFarland & Klein, 2005) 
 With regards to comorbidities, persistent depression is associated with a range 
of conditions: cardiac and respiratory syndromes, insomnia, pain other than 
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headache or backache, sexual problems, social phobia, benzodiazepine abuse, 
panic attacks, agoraphobia, obsessive-compulsive and generalized anxiety disorder, 
binge eating as well as neurasthenia (Angst et al., 2009; Gilmer et al., 2005). With 
regards to personality disorder it has been found that almost 50% of persistently 
depressed patients had at least one, most frequently Cluster C (avoidant, dependent, 
and obsessive-compulsive), comorbid personality disorder (Russell et al., 2003). 
 Beyond unsystematic reviews on factors associated with persistent depression 
(Klein & Santiago, 2003; Riso et al., 2002), Holzel et al. (2011) systematically 
reviewed the literature and identified younger age of onset, longer duration of 
depressive episodes, a history of affective disorders in the family, comorbid anxiety, 
personality, and substance abuse disorders, lower severity of depressive symptoms, 
as well as problems in the social environment as risk factors for the development of 
persistent depression. Evidence on other factors, that is, gender and age, alcohol 
abuse, critical life events, physical, and sexual abuse, substance abuse in the family, 
number of past depressive episodes, low socio-economic, educational and family 
status, was inconsistent (Holzel et al.; 2011).  
In terms of treatment outcome, persistent depression has been linked to worse 
response to pharmaco- and psychosocial therapy than episodic depression (e.g., 
Klein, 2008). 
2.1.3 Aetiology of persistent depression 
Finding on risk factors are integral to the multifactorial aetiological model of persistent 
depression which includes biological, psychological, and social components 
(Brakemeier et al., 2012) as well as to McCullough’s (2000) model of persistent 
depression on which he developed the disorder-specific CBASP.  
According to the multifactorial explanatory model (Brakemeier et al., 2012), the 
distal biological, psychological, and socio-cultural factors form patients’ vulnerability 
to develop persistent depression (Figure 2). The biological factors include genetics 
and all somatic influences on mental health or lack thereof. Examples of biological 
vulnerabilities are hormonal, physiological or pre/perinatal influences. Low self-
esteem, learning deficits, dysfunctional cognitions, neuroticism, lacking resources or 
skills, and early bonding disorders compose psychological vulnerabilities for 
persistent depression. Social-cultural risk factors include for example, aversive social 
conditions during upbringing, a lack of support and the experience of traumatic 
events. Together these represent vulnerabilities, which the multifactorial model also 
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refers to as scars. The model further assumes that the amplitude of these 
vulnerabilities or scars explains why confrontation with even slight stressors can 
trigger the onset and maintenance of depression (Brakemeier et al., 2012).  
Traumatic experiences and CM are particularly relevant to the explanatory 
model of persistent depression. This is because approximately two thirds of 
persistently depressed patients, especially those with an early onset of depression, 
report a history of significant CM (Klein & Santiago, 2003; Nemeroff et al., 2003; 
Schramm et al., 2011b; Wiersma et al., 2009). Most frequently reported forms of 
maltreatment are minor trauma, that is, emotional neglect and abuse; by contrast, 
physical and sexual abuse is reported less often (Schramm et al., 2011b; Wiersma et 
al., 2009). The multifactorial model incorporates that a history of CM and generally all 
traumatic events can trigger psychological and physiological reactions, such as 
intrusions or emotional dysregulation. These psycho-physiological reactions leave 
patients feel helpless, who due to their vulnerability may use dysfunctional coping 
strategies and may lack skills, resources and social support. Hence, patients may 
feel a sense of lost self-efficacy and unable to adequately process their emotional 
and cognitive experiences. This interplay of multifaceted vulnerabilities and acute or 
chronic stressors may explain why patients do not remit from acute depression and 
eventually experience persistent depression (Brakemeier et al., 2012).  
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Figure 2. Bio-psycho-social model for the development of persistent 
depression (adapted from Brakemeier & Hautzinger, 2008, as cited in 
Brakemeier et al., 2012, p. 21). 
 
In McCullough’s (2000) aetiological model of early onset persistent 
depression, CM is central to the development and maintenance of depression. 
According to McCullough (2000), CM leads to the cessation of normal cognitive-
emotional maturational processes in patients. Therefore, early onset persistently 
depressed patients exhibit preoperational features, otherwise observed in children 
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who are in the preoperational cognitive-emotional developmental stage as defined by 
Piaget (Piaget 1954/1981, as cited in McCullough, 2000): Global, prelogical 
reasoning, cognition which is hardly susceptible to logic or arguments, egocentrism, 
talking in monologue, a lack of empathy, and little emotional control when under 
stress. McCullough’s (2000) model (Figure 3) describes how persistent depression is 
the result of a vicious circle that begins with CM by significant others (e.g., the 
caregiver). Through their behaviour, the significant others create an abusive and/or 
neglecting environment. People who grow up and live within such threatening or 
even dangerous surroundings are likely to develop avoidance behaviour to escape 
from the imminence. This avoidance includes social and consequently cognitive and 
emotional withdrawal which ultimately leads to detached perception (Klein & Beltz, 
2014). By this, McCullough (2000) means that patients do not recognize their own 
effect on their surroundings, that is, other people. Detached perception also means 
that the environment has little to no impact on the cognition, emotion, and behaviour 
of the detached person (Klein & Beltz, 2014). McCullough (2000) argues that patients 
who are stuck in the preoperational cognitive-emotional stage keep others at a 
distance and are unable to see how their avoidant behaviour endangers satisfactory 
relationships. Moreover, he maintains that because of these preoperational features, 
patients find it difficult to make corrective experiences, which could challenge 
negative assumptions and foster more adaptive views on themselves and others. 
Therefore, patients cannot improve on their social skill deficits and continue to 
experience disappointment in social interaction. The latter reinforces social 
avoidance, maintains the hostile-submissive interpersonal style and thereby 
perpetuates the vicious circle of persistent depression (Klein & Beltz, 2014; 
McCullough, 2000).  
 Late-onset persistent depression, that is, after the age of 21, is also explained 
in terms of Piaget (Piaget,1954/1981, as cited in McCullough, 2000). For this group of 
patients McCullough (2000) assumes that intense emotionality in form of a 
depressive episode leads to the deterioration of the otherwise normal adult cognitive-
emotional development. The experience of the depressive episode ultimately causes 
the patient to regress to preoperational functioning. Arguably, McCullough’s 
aetiological model is best suited for the explanation of early onset persistent 
depression (Klein & Beltz, 2014). 
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Figure 3. McCullough’s model of persistent depression with integrated 
model of detached perception (adapted from Klein & Beltz, 2014, 
p. 15, 17). 
2.1.4 Treatments for persistent depression 
A combination of pharmacotherapy and psychotherapy is the recommended 
treatment for persistent depression and should be offered to the patient. Because of 
the high chronicity of persistent depression, both therapies should be continued as 
maintenance treatments after symptoms have declined (Berger et al., 2015; DGPPN, 
BÄK, KBV, & AWMF on behalf of the guidelines group for unipolar depression, 2015). 
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Since both pharmaco- and psychotherapy are recommended for treatment, this 
chapter will first provide a brief overview on pharmacotherapies before turning to 
psychotherapeutical approaches. 
2.1.4.1 Pharmacotherapy 
 Antidepressants are the most commonly prescribed drugs for persistent 
depression and therefore constitute the most relevant form of pharmacotherapy 
(Bschor, Bauer, & Adli, 2014). There are no differential indications for any 
antidepressant drug. Rather, the choice for a specific antidepressant should be made 
in consideration of a patient’s symptoms, earlier response to antidepressants, 
comorbidities and the drug’s side effects (Berger et al., 2015). Table 1 gives an 
overview on antidepressant drugs, common side effects, and risks.  
The efficacy of antidepressants in the treatment for persistent depression has 
been established in several studies. Meta-analyses on the efficacy of Tricyclic 
Antidepressants (TCA), Selective Serotonin Reuptake Inhibitors (SSRI) and 
Monoamine Oxidase Inhibitors (MAO-Inhibitors) in the treatment of patients with 
dysthymia or double depression found that antidepressants were superior to 
placebos; no significant differences in treatment efficacy were found between the 
drug classes (De Lima, Hotoph, & Wessely, 1999; Lima & Moncrieff, 2000). Similarly, 
in a more recent meta-analysis in patients with dysthymic disorder or double 
depression TCA and SSRI were superior to treatment in the placebo condition (von 
Wolff, Hölzel, Westphal, Härter, & Kriston, 2013). Other reviews on the treatment for 
medium or severe depressive episodes, chronic type conclude that antidepressants 
are more effective than placebo conditions (Kocsis et al., 2003; Michalak & Lam, 
2002). A meta-analysis found differential effects of several evidence-based 
treatment: Antidepressants are superior to placebos and the combination of 
psychotherapy (here, Interpersonal Psychotherapy (IPT)) and antidepressants is 
more effective than pharmacotherapy alone (Kriston et al., 2014). 
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Table 1 
Antidepressants, common side effects and risk 
Substance group and active ingredients Side effects and risks 
Tricyclic Antidepressants (TCA): 
• Amitriptyline, Clomipramine, 
Desipramine, Doxepine, Imipramine, 
Lofepramine, Nortriptyline, 
Trimipramine 
 
Tetracyclic Antidepressants: 
• Maprotiline 
Hal 
Anticholinergic and cardiovascular 
effects, orthostatic hypotension, 
sedation, increase in appetite and 
weight, overdose is potentially lethal  
Monoamine Oxidase Inhibitors (MAO-
Inhibitors): 
• Irreversible: Tranylcypromine 
• Reversible: Moclobemide 
Hall 
o 
Disturbed sleep, orthostatic 
hypotension, dry mouth; for 
tranylcypromine: risk of hypertensive 
crises, risk of serotonin syndrome 
when combined with serotonergic 
medication 
 
Selective Serotonin Reuptake Inhibitor 
(SSRI): 
• Citalopram, Fluoxetine, Paroxetine, 
Escitalopram, Fluvoxamine, Sertraline 
Hallo 
 
Nausea, restlessness, disturbed 
sleep, sexual dysfunction, syndrome 
of inappropriate ADH secretion; for 
Fluoxetine, Paroxetine, and 
Fluvoxamine: risk of interactions with 
other drugs 
 
Selective Norepinephrine Reuptake Inhibitor 
(SNRI): 
• Venlafaxine, Duloxetin 
 
 
Nausea, restlessness, sexual 
dysfunction, high blood pressure, dry 
mouth, diaphoresis syndrome of 
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inappropriate ADH secretion 
Autoreceptor blockers: 
• Mianserine, Mirtazapine 
 
Sedation, increase in appetite and 
weight; for Mianserine: risk of 
changes in blood count 
Others: 
• Trazodonea 
 
 
 
• Bupropion 
 
 
• Reboxetine 
 
Tiredness, nausea, dizziness, 
gastrointestinal and cardiovascular 
effects, dry mouth, hypotension, 
priapism 
Restlessness, disturbed sleep, 
headache, high blood pressure, dry 
mouth 
Tachycardia, orthostatic hypotension, 
inner restlessness, disturbed sleep, 
dry mouth, urogenital symptoms 
Notes. The table was adapted from Bschor and Adli (2008, Table 2); ainformation 
was added from the recommendations by the Drug Commission of the German 
Medical Association (2006). 
2.1.4.2 Psychotherapy 
The efficacy of psychotherapy in treating depression has generally been established; 
its outcomes depend however on the specific kind, severity and persistence of the 
depressive symptoms (DGPPN et al., 2015). With regards to persistent depression, 
literature on psychotherapy outcome studies is relatively scarce (de Jong-Meyer, 
Hautzinger, Kühner, & Schramm, 2007). The available empirical findings, 
summarized in a review, suggest that only 41% of patients with dysthymic disorder or 
double depression respond to Cognitive Behavioural Therapy (CBT) alone 
(Markowitz, 1994). 
Research indicates that psychotherapy alone is inferior to pharmacotherapy 
alone. Cuijpers et al. (2010) found that while psychotherapy alone had a significant 
small effect on outcome in samples with dysthymic patients, it was less effective than 
pharmacotherapy with SSRIs. Findings from a network analysis by Kriston et al. 
(2014) further elaborated that pharmacotherapy alone achieves better treatment 
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outcomes than IPT and Supportive Psychotherapy (SP) alone, but that 
pharmacological treatment fares equally well to CBASP and CBT alone.  
Moreover, combining pharmacotherapy with psychotherapy appeared more 
effective than treatment with either therapy alone (Cuijpers et al., 2010; DGPPN et 
al., 2015). More specifically, the combination of both treatments was more effective 
than monotherapy when patients experience a form of persistent depression other 
than dysthymia, when antidepressants other than SSRI were used, and when 
CBASP was not the studied psychotherapeutic intervention (Kriston, von Wolff, & 
Hölzel, 2010; von Wolff, Hölzel, Westphal, Härter, & Kriston, 2012). 
Findings that psychotherapy can achieve relatively satisfactory results when 
conducted for at least 18 sessions (Cuijpers et al., 2010) and that psychotherapy 
which is tailored to the specific needs of persistently depressed patients promotes 
outcome (Kriston et al., 2014) inspires optimism. However, despite the wide array of 
treatment options, persistent depression has been undertreated or not treated 
adequately. Kocsis et al. (2008) found that just 33% of persistently depressed 
patients in their study had ever had an adequate antidepressant treatment trial, with 
adequacy of treatment being defined by both duration and dose of an antidepressant. 
Analysis of routine data from a German health insurance indicated that 12% of those 
insurance holders with registered chronic depression were treated with a combination 
of pharmaco- and psychotherapy; 31% received no treatment at all and another 45% 
received pharmacotherapy alone, some of which did not get the minimal dose of 
antidepressant medication required to bring about clinical change (Melchior, Schulz, 
Härter, Walker, & Ganninger, 2014). When treated adequately, the prospect of 
success is still modest. Klein and Santiago (2003) state that “most patients eventually 
recover from chronic depression, but the recovery process can be prolonged and 
recurrence is common” (p. 814). 
2.2 Cognitive Behavioral Analysis System of Psychotherapy (CBASP) 
McCullough (2000) integrated cognitive, behavioural, interpersonal, and 
psychodynamic elements in order to develop the first disorder-specific psychotherapy 
for persistent depression, that is, CBASP. As explained in chapter 2.1.3, McCullough 
assumes that a history of CM leads to derailment of the cognitive-emotional 
maturation of early-onset persistently depressed patients. Alternatively, in late-onset 
persistently depressed patients, the experience of a depressive episode results in the 
regression to an earlier form of functioning. In both cases, McCullough (2000) 
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assumes that patients exhibit preoperational functioning which manifests itself in 
unsatisfactory interactions between the patients and their social environment on the 
behavioural, cognitive and emotional level. McCullough’s (2000) conceptualization of 
persistent depression is inherently interactional which is why he designed CBASP to 
be explicitly interpersonal. Hence, the alliance between patient and therapist 
becomes central. The alliance in CBASP differs from alliance in other forms of 
psychotherapy, such as CBT, in that firstly, therapists need to involve themselves 
personally and secondly, specific techniques are used to address patients’ issues in 
the transference to the therapist (McCullough, 2000; 2012).  
 In the following paragraphs the goals of CBASP will be outlined before 
describing its different interventions and procedures. At the end of this chapter, 
findings from outcome studies on treatment with CBASP will be summarized.  
2.2.1 Aims 
The overarching aim of CBASP is for patients to move beyond the preoperational 
towards to formal operational stage of reasoning, dissolve the perceptual detachment 
from the environment, to experience satisfactory relationships and genuine empathy 
as well as to overcome or at least manage the depression (McCullough, 2000). More 
specifically, CBASP pursuits the following goals (Brakemeier et al., 2012): (1) 
Patients should learn to understand the negative consequences of their behaviour. 
This should enable them to overcome helplessness and to gain self-efficacy. (2) 
Patients should understand their own and others’ stimulus character in order to gain 
empathy. (3) Patients should learn how to obtain goals in interpersonal situations. (4) 
Patients should overcome the impact of earlier abuse and neglect on interpersonal 
situations. 
2.2.2 Methods 
McCullough (2000) drew insights from Piaget (theory on cognitive-emotional 
development), Skinner (operant learning), Seligman (learned helplessness), Beck 
(cognitive model of depression), Bandura (social learning theory), Kiesler 
(interpersonal theory), and Freud (transference and therapeutic alliance) in the 
development of CBASP. Despite the conceptual proximity to the above pioneers in 
psychology, the following interventions are unique to CBASP and distinguish it from 
other psychotherapeutic approaches (McCullough, 2000, 2012):  
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• Significant-other history (SOH): The SOH is a systematic assessment of how 
the past behaviour of significant others have influenced patients. To this end, 
therapists will begin by asking patient to name 4 to 6 significant others and to 
describe their behaviour towards them. Following that, therapist seek to draw 
causal inferences by asking questions like “Now, what effect has your 
mother’s behaviour had upon the way you live?”, “How has your life been 
influenced by your mother?”, “What kind of person are you today because of 
your mother’s influence?” (McCullough, 2000, p.88). Subsequently, patients, 
guided by therapists, deduct causal associations on the impact that the 
significant others have had on them and their interpersonal expectations. 
• Transference hypotheses: Based on the preliminary causal associations, 
therapists and patients then formulate transference hypotheses for the 
following four domains: (1) interpersonal intimacy, (2) emotional needs, (3) 
failure or mistakes, and (4) negative affect.  
Unknowingly encountered in therapy, transference regarding the above 
domains may present ruptures to the alliance between patient and therapist. 
Hence, therapists should know about these hot spots in order to purposefully 
use them for the therapeutic process.  
• Interpersonal discrimination exercise (IDE): The IDE aims at teaching patients 
that negative experiences they made in the past will not repeat themselves in 
the interaction with the therapists. The IDE allows patients to feel safe in the 
therapy and enables them to gain new relational experiences so that the 
interpersonal trauma can heal. McCullough (2000) calls it offering the patient 
“new interpersonal realities” (p. 187). This experience, when made explicit by 
therapists, helps patients challenge their global, negative social expectations. 
The IDE describes a procedure in which therapists contrast their own 
benevolent reactions to patients’ hot spots with the maltreatment that patients 
used to receive by significant others. Therapists may do this by asking the 
following questions: (1) ‘How did I react when you told me that you were (e.g.) 
feeling sad an anxious?’, (2) ‘How would your mother (and other significant 
others) react, when you (e.g.) told her about your negative feelings?’, (3) 
‘What is the difference between your significant other’s (here, mother’s) 
reaction and my reaction?’, (4) ‘What does it mean to you that I reacted 
differently?’ (Brakemeier et al., 2012) 
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• Disciplined personal involvement (DPI): In contrast to other forms of 
psychotherapy, CBASP demands of therapists to personally open up to 
patients - in a disciplined way – and thereby actively shape the alliance. There 
are three reasons behind DPI: (1) Therapists act as models for patients, 
teaching them how to open up personally and engage in empathetic 
encounters. (2) Patients learn to discriminate between experiences within the 
alliance to therapists and early dysfunctional relationships only through 
therapists’ genuine personal reactions. (3) In openly displaying reactions to 
patients’ hostile behaviour, patients can learn that their behaviours have 
negative consequences on others’ feelings. CBASP distinguishes between 
positive and negative DPI. An example of a positive DPI is: ‘I am very happy, 
you managed to be on time today.’ An example of a negative DPI is: ‘I am 
realizing how sad it makes me feel to hear you say that you don’t trust me.’ 
(Brakemeier et al., 2012) 
• Kiesler’s interpersonal circle: The circle is a graphic depiction of the Impact 
Message Inventory (IMI; Kiesler & Schmidt, 1993). The IMI is a self-report 
questionnaire which assesses covert cognitive, emotional, and behavioural 
reactions a person triggers in others. Results from the IMI can be mapped 
onto Kiesler’s interpersonal circle, which then illustrates the impact of 
someone’s interpersonal style (Figure 3). The interpersonal circle is mapped 
against two orthogonal axes which represent the interpersonal dimensions 
control and affiliation. Control runs vertically from one extremity (dominant) to 
the other (submissive). Horizontally, the axis affiliation depicts the continuum 
from hostile to friendly. It follows that there are interpersonal octants: 
dominant, hostile-dominant, hostile, hostile-submissive, submissive, friendly-
submissive, friendly, and friendly-dominant. The assumption of 
complementarity is the circle’s underlying rational. Complementarity herein 
means that any interpersonal style triggers behaviours from the counterpart, 
which are complementarily mirrored over the axis of affiliation. Patients’ 
hostile-submissive style triggers (unhelpful) hostile-dominant behaviour from 
therapists. In CBASP, the interpersonal circle is used for therapists to 
understand how to shape the alliance, in order not to elicit destructive, “knee-
jerk responses” (McCullough, 2000, p. 171) in patients. In addition to that, the 
interpersonal circle finds application in later stages of therapy to help patients 
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understand and modify their own impact on others (Brakemeier et al., 2012; 
McCullough, 2000). 
 
 
Figure 3. Kiesler’s interpersonal circle and the octant complementarity 
(adapted from McCullough, 2000, p. 172). 
 
• Situational analysis (SA): As depicted in Figure 4, SA constitutes the major 
intervention in CBASP and dominates the psychotherapeutic process 
(Brakemeier et al., 2012). According to (McCullough, 2000), SA trains patients 
to overcome preoperational reasoning in several ways: (1) it constrains 
patients to focus on one specific situation rather than to think globally; (2) SA 
demonstrates to patients their interpersonal impact; (3) SA teaches patients 
the consequences of their behaviour towards others. In addition to that, (4) 
during SA, patients engage in dialogue rather than in their habitual 
monologue. Lastly, (5) SA points out to patients that they benefit from more 
adaptive social behaviours. SA is conducted by means of work sheets, which 
structure SA in that they outline its steps. SA can be subdivided into a phase 
of exploration and a phase in which a solution is found. In the earlier phase, 
patients learn to describe and interpret difficult interpersonal situations. They 
recognize the causal link between their behaviour and its often unsatisfactory 
outcome. In the latter phase, therapists guide patients to revise their earlier 
global interpretation of the situation and make it more specific. Additionally, 
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patients learn to modify unhelpful behaviour so that it becomes more 
constructive. This way, patients experience that their actions have impact and 
thereby gain self-efficacy. In a final step, patients are asked to draw 
conclusions and to transfer their new knowledge to other situations. Initially, 
therapists guide patients through SA, but later ask patients to do SAs on their 
own (Brakemeier et al., 2012; McCullough, 2000). 
CBASP is a very structured form of psychotherapy. Figure 4 displays a possible 
course of psychotherapy for persistent depression with CBASP. Initially, the focus 
lies on understanding patients’ biographies, their individual history becoming 
persistently depressed and on arriving at a sound diagnosis. Following that, 
therapists will guide patients to develop a list of significant others and assess the 
SOH. Subsequently, therapists and patients will jointly work on formulating the 
transference hypotheses. The exact number of sessions necessary to collect this 
information may vary. Yet, usually after the 5th or 6th session, SAs begin to be the 
focal point of each session. SA may include roleplays and reference to Kiesler’s 
circumplex where appropriate. What is more, therapists are encouraged to apply IDE 
and DPI where appropriate (Brakemeier et al., 2012; McCullough, 2000).  
 
 
Figure 4. Course of therapy for persistent depression with CBASP (adapted from 
Brakemeier et al., 2012, p. 36). 
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2.2.3 Efficacy and effectiveness 
Some of the following studies in samples of persistently depressed patients were 
already touched upon in chapter 2.1.4 but will be summarized here in more detail and 
with specific regards to CBASP.  
 The first study to establish CBASP as a reasonable treatment option was a 
large trial by Keller and colleagues (2000), which compared the relative efficacy of 12 
weeks outpatient treatment with nefazodone, CBASP or both. Treatment with CBASP 
consisted of 16 to 20 sessions. Of the 662 patients included in the analysis, almost 
50% responded (or remitted) in the medication and CBASP alone treatment groups. 
When treatment was combined, though, response significantly increased to 73% in 
the third intervention group. For patients, who completed the study, response rate 
was even higher (nefazodone alone: 55%, CBASP alone: 52%, combined treatment: 
85%). Dropout was similar in all groups. In a reanalysis of the data, it was found that 
for patients with a history of CM, CBASP was more effective than antidepressants 
and that the combination of CBASP and pharmacotherapy was just slightly more 
beneficial than monotherapy when comparing symptom change relative to the first 
week of treatment (Nemeroff et al., 2003, 2005). Patients who had not responded to 
12 weeks of treatment with nefazodone or CBASP alone were included in another 
study (Schatzberg et al., 2005). Schatzberg and colleagues (2005) conducted a 
crossover trial to investigate if the non-responders would benefit from the other 
treatment option, respectively. They treated patients, who had not responded to 
medication, with 12 weeks of CBASP and prescribed CBASP for 12 weeks to non-
responders of nefazodone. Results indicated that a switch from one form of treatment 
to the other was beneficial: almost 60% of non-responders to monotherapy with 
nefazodone responded to CBASP, and over 40% of CBASP non-responders 
responded after having switched to medication. When CBASP (22 sessions) was 
compared to treatment with escitalopram (plus clinical management), results 
indicated that there was no significant difference in decrease of clinician-rated 
symptom severity 8 and 28 weeks into treatment (Schramm et al., 2015). For those 
study participants who did not show improvement after 8 weeks, treatment was 
augmented by adding the respective other treatment condition for the following 20 
weeks. After 28 weeks both treatment groups were similarly effective with regards to 
response and remission. Moreover, initial non-responders benefitted from 
augmentation to the effect that at the end of treatment there were no differences to 
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initial improvers any more. A large multicentre study called REVAMP trial (Research 
Evaluating the Value of Augmenting Medication with Psychotherapy; Kocsis et al., 
2009) investigated the additional effects of CBASP versus brief Supportive 
Psychotherapy (BSP) versus optimized pharmacotherapy on response and remission 
in a sample of patients receiving algorithm-guided pharmacological treatment for 12 
weeks. Augmentation treatment lasted another 12 weeks after which there were no 
significant differences between the three treatment groups.  
There are only few studies comparing the efficacy of CBASP to other 
psychotherapies. In a pilot study by Schramm et al. (2011b) on the comparison 
between CBASP and IPT, 30 patients were randomized to CBASP or IPT (22 
sessions in 16 weeks). Results indicated that CBASP led to better remission (57%) 
than IPT (20%), but that one year post treatment, there were no significant 
differences in self-reported symptoms. Recently a multicentre study by Schramm et 
al. (2017) comparing the efficacy of CBASP versus supportive psychotherapy (SP), in 
which treatment lasted for 48 weeks and included 32 individual sessions, found that 
CBASP was more effective in reducing depressive symptoms. More specifically, 
patients in the CBASP condition had significantly lower levels of depressive 
symptoms than patients receiving SP after 20 and 48 weeks of treatment. After 20 
weeks 39% of patients undergoing CBASP reached response whereas only 24% in 
the SP condition did. Similarly, significantly more patients in CBASP reached 
remission (22%; SP: 13%). Another study compared the efficacy of mindfulness-
based cognitive therapy (MBCT) plus treatment as usual (TAU) versus CBASP plus 
TAU versus TAU alone (Michalak et al., 2015). CBASP and MBCT lasted 8 weeks 
and were conducted as group therapy. CBASP was significantly more effective in 
reducing depressive symptoms than TAU; findings for MCBT were equivocal.  
There is one German non-controlled trial investigating outcome and feasibility 
of inpatient treatment with CBASP (Brakemeier et al., 2015). In the study, CBASP 
was conducted in form of a 12-week inpatient program. 70 inpatients with persistent 
depression or treatment resistant depression participated in the study. Most patients 
(76%) responded and 40% of patients remitted after inpatient treatment with CBASP. 
When depressive symptoms were assessed in follow ups, response was initially 
(after 6 months) still high but declined to approximately 50% after 12 months.  
 A Dutch study investigated the effectiveness of CBASP (Wiersma et al., 2014). 
139 patients, who could take additional medication, were assigned to either CBASP 
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or care as usual (CAU). Patients received on average 23 sessions of outpatient 
psychotherapy over a period of 52 weeks. There was no significant difference in 
symptom severity after 8, 16, and 32 weeks, but patients receiving CBASP showed a 
significantly greater decline in depressive symptoms than patients who received 
CAU. 
 There are two meta-analyses that make specific reference to CBASP. In a 
network meta-analysis, Kriston et al. (2014) stated that CBASP was more effective 
than IPT and similarly effective to medication alone. They note, that findings on the 
efficacy of CBASP plus pharmacotherapy remains equivocal, which may be due to 
moderating effects of symptom severity. A later meta-analysis concluded that 
CBASP, as compared to other treatments or TAU, appeared to have a small effect. In 
comparison to TAU and IPT, CBASP has a moderate to high effect, and a similar 
effect compared to medication alone. Medication plus CBASP had a larger affect 
than antidepressant medication alone (Negt et al., 2016).  
As has been mentioned before in this dissertation, CM is an important risk 
factor for the development and maintenance of persistent depression (e.g., Wiersma 
et al., 2009). Moreover, McCullough’s (2000) aetiological model for early onset 
persistent depression uses CM as a starting point for the explanation of persistent 
depression and for the development of CBASP. Therefore, studies investigated 
whether a history of CM serves as an indication for CBASP. Recently in a subgroup 
analysis of the trial comparing the efficacy of CBASP versus SP (Schramm et al., 
2011, 2017), the presence of CM appeared to have a moderating effect on the 
superiority of CBASP (Klein et al., 2018). Likewise, another study found that for 
patients with a history of CM, CBASP was more effective than antidepressants and 
that the combination of CBASP and pharmacotherapy was just slightly more 
beneficial than monotherapy when comparing symptom change relative to the first 
week of treatment (Nemeroff et al., 2003, 2005). Yet, in a smaller and underpowered 
study, pharmacological treatment with escitalopram and treatment with CBASP led to 
a comparable treatment response in patients with and without CM (Bausch et al., 
2017).  
2.3 Supportive Psychotherapy 
Supportive psychotherapy (SP) may be the most commonly employed form of 
psychotherapy (Tanielian, Marcus, Suarez, & Pincus, 2001). Yet, it lacks a sufficient 
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definition (Douglas, 2008) and is sometimes inaccurately used as an “umbrella term” 
or “synonym for eclectic therapy” (Markowitz, 2014, p. 285, 286). More specifically, 
SP can be defined as a form of psychotherapy in which „the therapist strives to 
create a supportive relationship by emphasizing nonspecific therapeutic interactions 
and techniques that convey to the patient the therapist’s interest, concern, and 
understanding. It emphasizes the patient’s strengths and assets.“ (Markowitz & 
Sacks, 2002, p. 6) 
In psychotherapy research, SP is commonly studied in either of two ways: 
either as a genuine treatment in itself or, more often than not, as the comparator, or 
control condition, to an experimental treatment (Cuijpers et al., 2012). This 
dissertation comprises two studies in which data from a multicentre randomized 
controlled trial (RCT) were used (Schramm, 2015). In this RCT, manualized SP was 
employed as the nonspecific active control condition. In describing the aims and 
methods of SP, I will therefore rely on the manual adhered to in the RCT (Markowitz 
& Sacks, 2002). 
2.3.1 Aims 
SP pursues the common factors of psychotherapy, namely facilitation of affect, 
establishing a relationship in which patients feel understood, a treatment rationale, 
empathy, a treatment ritual, experiences of success, fostering hope and therapeutic 
optimism (Markowitz & Sacks, 2002). These nonspecific factors have been studied 
intensively and are assumed to account for most variance in psychotherapy outcome 
(e.g., Wampold & Imel, 2015).  
2.3.2 Methods 
The methods employed to achieve the above aims are outlined below. Some 
methods may be integral to other forms of psychotherapy, such as CBT, too. In order 
to differentiate SP from other psychotherapies, Markowitz & Sachs (2002) therefore, 
additionally explicate behaviours a therapist is to avoid in SP. 
• Supportive relationship: Similarly to Rogers’ (1951) core conditions of 
empathy, congruence and unconditional positive regard, SP therapists should 
seek to establish a genuine warm, interested, understanding alliance in which 
the patient can feel safe. This supportive alliance is the imperative to SP. 
Therapists should promote a positive alliance by means of a facing body 
posture and by seeking affect. The latter can be achieved by for example, 
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repeating emotional utterances by the patient or by adding understanding, 
affirmative interjections (Markowitz & Sacks, 2002).  
• Strengths and assets: Whenever possible, therapists should point out patients’ 
skills, strengths, prior successes or adaptive coping experiences. This may 
also include positive reframing of characteristics patients perceive negatively. 
By reminding patients of their resources, they may begin to overcome 
hopelessness (Markowitz & Sacks, 2002). 
• Therapeutic stance: The role of therapists in SP is to be the patients’ allies. 
Therapists should verbally and non-verbally welcome, encourage and 
reinforce patients. Therapists should follow patients’ lead throughout therapy 
and provide only subtle guidance. Therapists should facilitate patients to 
express and reflect on their emotional experience (Markowitz & Sachs, 2002). 
• To be avoided behaviours: In SP, therapists should refrain from specific 
techniques inherent to other forms of psychotherapy, such as CBASP, CPT, 
IPT or psychodynamic techniques. Therapists should for example, not assign 
homework, interpret patients’ dreams or actively solve patients’ problems. 
Rather, therapists should facilitate patients to arrive at their own solutions 
(Markowitz & Sacks, 2002).  
 
In their manual, Markowitz and Sacks (2002) differentiate between an initial, 
middle and closing phase of treatment. To further illustrate SP, exemplary elements 
of the three different phases will be explicated.  
In the beginning of SP, therapists should welcome patients, explore the 
reasons for seeking treatment and understand the history of the present problems. In 
addition to that, the first sessions should be used to do the housekeeping and to 
accustom patients to the therapeutic setting and tone. Moreover, therapists should 
strive to foster the therapeutic alliance verbally and non-verbally. An example of non-
verbally strengthening the alliance can be to lean forward; by using the proverb ‘we’, 
therapists can verbally underscore the alliance. Moreover, therapists should minimize 
ruptures to the alliance, by for example, illuminating patients’ negative reactions to 
the treatment and resolving potential upset on part of the patients (Markowitz & 
Sacks, 2002).  
In the middle phase, treatment topics usually narrow down to one critical 
theme. In the case of persistently depressed patients, this theme may be related to 
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self-hatred, distress, anhedonia or unhappy relationships. Therapists should refrain 
from active interventions and facilitate patients to arrive at their own conclusions on 
how to deal with the circumstances. To do so, therapists could for example, 
normalize patients’ problems, educate patients about their problems or focus on 
adaptive coping skills. Other supportive techniques include explicitly encouraging 
patients and guiding patients through their experience of negative affect (Markowitz & 
Sacks, 2002). 
In the closing phase of SP, therapists should invite patients to review the 
therapy by talking about how the patients’ understanding of their problems have 
developed over the course of treatment. Additionally, therapists and patients should 
address remaining issues of patients, and patients may be provided with contact 
details for further support (Markowitz & Sacks, 2002).  
In contrast to more structured, directive psychotherapies such as CBASP, it 
is difficult to manualise exactly what therapists have to do. Yet, research shows that 
therapists are able to adhere to SP (Markowitz, Spielman, Scarvalone, & Perry, 
2000). 
2.3.3 Efficacy 
SP has been studied extensively, mainly as a comparator to an experimental 
treatment condition, and has fared well in many research trials covering diverse 
diagnoses (Cuijpers et al., 2012; Markowitz, 2014). In comparison to other disorder-
specific treatments, SP reached comparable results in treating anorexia nervosa 
(McIntosh et al., 2005) and social phobia (Lipsitz et al., 2008). Regarding personality 
disorders, SP was found to be generally as effective as Transference-Focused 
Psychotherapy (TFP) and Dialectical Behavioral Therapy (DBT) in treating borderline 
personality disorder (Clarkin, Levy, Lenzenweger, & Kernberg 2007). In another 
study comparing SP to dynamic psychotherapy, both treatments were equally 
effective in treating patients suffering from a Cluster C personality disorder 
(Hellerstein et al., 1998). With regards to depressive disorders, results were similar: 
In contradiction to the study’s hypothesis, SP fared equally well as CBASP in treating 
persistently depressed patients in a large trial (Kocsis et al., 2009). In another study 
on the effects of psychotherapy on persistently depressed patients, SP and IPT had 
comparable antidepressant effects (Markowitz, Kocsis, Bleiberg, Christos, & Sacks, 
2005). In a sample of depressed patients who were HIV-positive, treatment outcomes 
of patients receiving SP were comparable to patients receiving CBT (Markowitz, 
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Kocsis, Fishman, & et al., 1998). In a meta-analysis, Cuijpers et al. (2012) found that 
SP was effective, less so than other psychotherapies, though. Yet, the latter effect 
may be due to researcher allegiance, that is, the extent to which a researcher 
identified with or favoured one treatment over the other. This means that after 
controlling for allegiance, SP is arguably comparably effective to other psychological 
treatments (Markowitz, 2014).  
2.4 Alliance 
The concept of alliance will be described by firstly explicating its historical roots (cf. 
Horvath, 2000). Following that, the most frequently used instruments to measure 
alliance will be introduced. Lastly, findings on the relationship between alliance and 
outcome will be summarized. Specific results from the scarce body of literature on 
the alliance-outcome link in treatment with CBASP will be presented.  
2.4.1 Historical roots 
The concept of alliance between patient1 and therapist is rooted in the writings by 
Freud (Horvath & Luborsky, 1993). Freud regarded the therapeutic relationship, 
which in this dissertation is referred to as alliance, as the positive transference of the 
patient onto the therapist (Freud, 1913). This perspective underscored the 
intrapsychological and neurotic component of the relationship. Since Freud 
understood the alliance as the product of transference, it was subject to the 
psychoanalytic process and was meant to dissolve (Horvath, 2000). Later, Freud 
(1913) expanded this conceptualization by a reality-based form of attachment 
(Horvath & Luborsky, 1993). Yet, the importance he assigned to transference 
becomes apparent when he writes: “It [transference] is a universal phenomenon of 
the human mind, it dominates the whole of each person’s relations to his human 
environment” (Freud, 1927/1961, as cited in Flückiger et al., 2018, p. 2). 
 Other analysts later followed up on the idea that transference may be 
separable from a reality based form of the relationship, and developed different 
conceptualizations of the alliance between patients and therapists. It was Zetzel 
(1956), who coined the term therapeutic alliance. She proposed that in 
                                            
1 In the literature on alliance, patients are often referred to as clients (e.g., Flückiger, Del Re., 
Wampold, & Horvath, 2018). In this dissertation, the term patient(s) will be used for the sake of 
consistency.  
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psychoanalysis, patients need to vacillate between transference and a non-neurotic 
therapeutic alliance with the therapist. The term working alliance was coined by 
Greenson who defined it as:  
the relatively nonneurotic, rational rapport which the patient has with his 
analyst. It is this reasonable and purposeful part of the feelings the patient has 
for the analyst […]. It can be seen at its clearest when a patient, in the throes 
of an intense transference neurosis, can yet maintain an effective working 
relationship with the analyst. (Greenson, 2008, pp. 79-80) 
Beyond psychoanalysis, Rogers (1951) developed client-centred 
psychotherapy. There, empathy, congruence and unconditional positive regard on 
behalf of therapists towards patients are sine qua non for the alliance. Rogers 
assumed these three variables to be curative, sufficient and necessary for the patient 
to grow and heal. According to Horvath (2000), the school of behaviourism and 
behavioural psychotherapy had adopted the view that therapists are teachers to 
patients, instructing them in new and more adaptive skills and behaviours. Here, the 
alliance between patient and therapist was traditionally regarded as the by-product or 
consequence of therapeutic interventions. Only later did the behaviouristic school of 
psychotherapy assume that it was the alliance which created the environment in 
which techniques could operate (Horvath, 2000). An alternative conceptualization, 
brought forward by attachment theorists, holds that “the client, as part of the therapy 
process, develops the capacity to form a positive, need-gratifying relationship with 
the therapist” (Horvath & Luborsky, 1993, p. 561). 
Later, based on Freud’s explanations, Luborsky (1976) introduced the helping 
alliance which he defined as “the patient’s experience of the treatment or relationship 
with the therapist as helpful or potentially helpful” (Alexander & Luborsky, 1986, p. 
326). The helping alliance is assumed to constitute two types: Type I - the perceived 
supportiveness of the therapist and Type II - the joint working on treatment goals 
(Luborsky, 1976; Luborsky, 2000). Luborsky further assumed that Type I was more 
pronounced at the beginning of a therapy, whereas Type II was more dominant in the 
later stages of the process. While Luborsky’s theory originated from classic 
psychoanalytic writings, his conceptualization of the helping alliance has been 
applied to treatment forms over and above psychoanalysis (Flückiger et al., 2018).  
 Based on Greenson’s working alliance, Bordin (1979) formulated a deliberate 
pantheoretical conceptualization of alliance, which comprises three components: 
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goals, tasks, and bonds. By goals Bordin means the mutually agreed upon goals of 
the therapeutic intervention. Tasks refer to certain behaviours inherent to the 
psychotherapeutic practise (e.g., free association or repeating certain behaviours) 
and bonds represent the nature of the relationship and include for example, trust or 
liking. Further, Bordin assumed that goals, tasks, and bonds constituted the alliance 
in all forms of treatments, but that the weighing of components varied between 
treatments (Flückiger et al., 2018). 
 Generally, interest in a pantheoretical conceptualization of the alliance 
increased as the accumulating body of literature on therapy outcome indicated that it 
was not any one method of therapy, but rather one general factor, which best 
predicted therapy outcome (Horvath, 2000). 
2.4.2 Operationalisations and research instruments 
The scientific engagement with the alliance construct gave rise to the development of 
numerous measurement instruments. Among the most prominent ones are the 
Pennsylvania Helping Alliance Scales (Alexander & Luborsky, 1986; Luborsky, Crits-
Christoph, Alexander, Margolis, & Cohen, 1983; Luborsky, McLellan, Woody, 
O'Brien, & Auerbach, 1985; Morgan, Luborsky, Crits-Christoph, Curtis, & Solomon, 
1982), the Vanderbilt Psychotherapy Process Scales (VPPS; Suh, Strupp, & 
O'Malley, 1986), the Working Alliance Inventory (WAI; Horvath & Greenberg, 1989), 
and the California Psychotherapy Alliance Scales (CALPAS; Marmar, Gaston, 
Gallagher, & Thompson, 1989) (Flückiger, Horvath, Del Re, Symonds, & Holzer, 
2015; Hatcher & Barends, 2006). In fact, about two thirds of all studies included in a 
recent meta-analysis on the link between alliance and outcome were based on some 
version of the above instruments (Flückiger et al., 2018), which have acceptable 
reliability (Martin et al. 2000). An exploratory factor analysis on the WAI, CALPAS 
and one of the Pennsylvania Helping Alliance Scales found that common to the 
instruments was a factor called Confident Collaboration (Hatcher & Barends, 1996). 
As the studies in this dissertation employed one of the Pennsylvania Helping 
Alliance Scales, they will be described in more detail. The Pennsylvania Helping 
Alliance Scales are based on Luborsky’s (1976) concept of the helping alliance and 
seek to measure both types of the helping alliance, that is, the patient perceiving the 
therapist as helpful and supportive and working together towards common goals. At 
first, Luborsky and colleagues developed the Helping Alliance Global Rating Method 
(HAr; Morgan et al., 1982) and the Helping Alliance Counting Sign Method (HAcs; 
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Luborsky et al., 1983). Both instruments rely on observer ratings and are highly 
correlated (Luborsky et al., 1983). Later, the Helping Alliance Questionnaire was 
developed as a self-rating instrument (HAq; Luborsky et al., 1985). The HAq was 
subsequently revised into the HAq-II. The Haq-II was short off 6 items on early 
symptomatic improvement and complemented by 14 items on the collaboration 
between patients and therapists, on how patients perceived therapists and on how 
patients perceived therapists feeling toward them (Luborsky et al., 1996). Because 
the HAq-II lacks psychometric testing and application in the literature, the HAq is still 
commonly used and recommended (Elvins & Green, 2008; Martin, Garske, & Davis, 
2000; Nübling et al., 2017).  
2.4.3 Findings on the alliance-outcome link in psychotherapy 
By means of these and other research instruments on the alliance, research has 
generally been concerned with four broad areas: firstly, how does alliance relate to 
therapy outcome? Secondly, how does therapy outcome relate to alliance as 
assessed from various standpoints, that is, self-ratings, patient, therapist, and 
observer ratings? Thirdly, what is the size of the alliance-outcome link at different 
times over the course of therapy? And lastly, how does alliance emerge and develop 
over time? (Horvath, 2005). 
 Several meta-analyses have investigated primary studies on the association 
between alliance and therapy outcome. Indeed, Horvath and Symonds (1991) 
included 24 studies in their meta-analysis and found a moderate association between 
a good working alliance and outcome - with clients’ assessments of alliance being the 
best predictor. Moreover, their meta-analysis showed that the magnitude of the 
correlation between alliance and outcome did not significantly vary with treatment 
type or number of treatment sessions (Horvath & Symonds, 1991). Similarly, Martin 
et al. (2000) and Horvath et al. (2011) found a moderate alliance-outcome link, which 
was not substantially influenced by a number of moderator variables (e.g., type of 
treatment). Later meta-analyses paralleled earlier findings and thereby supported the 
notion that there is a medium association between alliance and outcome (Del Re, 
Flückiger, Horvath, Symonds, & Wampold, 2012; Flückiger et al., 2015). The latest 
meta-analysis did not only confirm the robustness of the alliance-outcome link but 
could further provide evidence that the alliance is indeed a causal predictor of 
therapy outcome (Flückiger et al., 2018). 
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 Only 2 studies have examined the alliance-outcome link in treatment for 
persistent depression with CBASP. A study which analysed data from the study by 
Keller et al. (2000) found that after controlling for earlier symptom improvement and 
several patient characteristics (e.g., gender or history of abuse and neglect), patient-
rated early alliance predicted subsequent reduction in depressive symptoms. 
Additionally, the study observed that patients who had received combined treatment 
of CBASP and pharmacotherapy had higher alliance ratings than patients receiving 
CBASP alone. The positive effect of alliance on treatment outcome, that is, 
depressive symptoms, was similar in both treatment conditions (Klein et al., 2003). 
Similarly, an analysis on the Kocsis et al. (2009) data found that early alliance ratings 
by patients, who were treated with either CBASP or BSP predicted depressive 
symptoms improvement after controlling for prior depression reduction and global 
functioning at baseline. The alliance-outcome link was more pronounced in the group 
of patients receiving CBASP (Arnow et al., 2013). Both studies considered the 
reverse hypothesis, that is, that alliance resulted from a reduction in depressive 
symptoms. The findings however indicated that in treatment with CBASP better 
alliance facilitates better treatment outcome (Constantino et al., 2016). 
 Generally, 2 mechanisms have been proposed to explain the alliance-outcome 
link in CBASP: In the first mechanism, a quality alliance acts as a precondition in 
which the specific techniques of CBASP, such as SA, can be effective. In the second 
mechanism, a sound alliance enables the patient to make new and corrective 
relational experiences which are a precondition for interpersonal change to occur 
(Constantino et al., 2016). The first putative mechanism was investigated in a 
reanalysis of the data by Keller et al. (2000). Results showed that a specific skill 
taught in CBASP, SA, did not mediate the association between alliance and 
treatment outcome and therefore rejected the explanatory model (Santiago et al., 
2005). Another reanalysis of the same dataset supported the second possible 
mechanism (Constantino et al., 2016). The authors found that the alliance-outcome 
link was mediated by patients’ interpersonal change: Higher patient-rated early 
alliance predicted a decrease in hostile-submissiveness which was associated with 
lower depression at the end of treatment. These findings support CBASP change 
theory which posits that the alliance can positively impact the interpersonal 
functioning and that such changes positively influence the symptoms of persistently 
depressed patients (Constantino et al., 2016). 
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 All in all, the literature on the alliance-outcome link supports the notion that the 
alliance between patient and therapist is central to treatment in general and to 
treatment of persistent depression with CBASP in particular.  
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3 AIMS AND HYPOTHESES 
Despite the alliance being central to CBASP, little is known about how CBASP effects 
the alliance. This dissertation sought to investigate the alliance between persistently 
depressed patients and their therapists who received either the disorder-specific 
CBASP or the non-specific SP. In order to study the alliance in CBASP, this 
dissertation intended to firstly, examine the psychometric properties of the German 
HAq (hereafter spelled HAQ), which was translated by Bassler et al. (1995) and is 
available for patients (HAQ-P) and therapists (HAQ-T). The authors propose that the 
HAQ has a two-dimensional structure with the factors ‘satisfaction with therapeutic 
outcome’ and ‘relation to the patient/therapist’ The HAQ is a highly important 
instrument in psychotherapy research (Elvins & Green, 2008; Nübling et al., 2017; 
Wampold & Imel, 2015). Yet, there is inconclusive evidence on its psychometric 
properties (Nübling et al., 2017; Puschner, Bauer, Horowitz, & Kordy, 2005). 
Furthermore, psychometric examination of the German HAQ-T is lacking entirely. 
Hence, Study 1 aimed at expanding on the literature on the HAQ by investigating the 
specific psychometric aspects of the German HAQ-P and HAQ-T. Study 1 was 
guided by the hypotheses below: 
• The patient and therapist version of the HAQ (HAQ-P and HAQ-T) 
consist of two theoretically proposed factors, that is, ‘satisfaction with 
therapeutic outcome’ and ‘relation to the patient/therapist’ (hypothesis 
1). 
• The resulting subscales ‘satisfaction with therapeutic outcome’ and 
‘relation to the patient/therapist’ are reliable and convergently valid 
(hypothesis 2).  
 
Study 2 investigated how the patient-rated alliance between persistently 
depressed patients and their therapists developed over the course of a 48-week long 
treatment with either CBASP or SP. McCullough (2000) posits that CM is aetiological 
for characteristics which impede the formation of a positive alliance. McCullough 
(2000) further argues that persistently depressed individuals necessitate a distinct 
personal therapeutic relationship with their therapist. Hence, unlike in other forms of 
treatment, CBASP entails specific techniques which are aimed at enabling the patient 
to make new relational experiences with the therapist (McCullough, 2000, 2012). So 
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far, the positive effect of CBASP, as compared to BSP, on the average patient-rated 
alliance has been established in only one study (Arnow, 2013). This dissertation 
investigated both the overall average differences in alliance ratings between CBASP 
and SP as well as the development of alliance ratings over time. In addition to that, it 
was examined whether CBASP and SP have differential effects on the course of 
alliance ratings between patient groups with distinct degrees of CM. 
Based on the results by Arnow et al. (2013) and the assumptions of CBASP 
theory, Study 2 tested the following hypotheses: 
• CBASP has a more positive effect on the therapeutic alliance than 
supportive psychotherapy (SP) (hypothesis 1). 
• Alliance improves over the course of therapy with CBASP and SP 
(hypothesis 2). 
• The increase in alliance ratings is most pronounced in patients with 
severe CM receiving CBASP (hypothesis 3). 
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4 METHODS 
Both, Study 1 and 2, analysed data from a large multicentre, observer blind, 
prospective, parallel-group, randomized controlled trial (RCT) on the comparative 
efficacy of CBASP versus SP for early onset persistent depression (Schramm et al., 
2011). The RCT was conducted at 9 university centres in Germany: (1) Department 
of Clinical and Developmental Psychology, University of Tuebingen, Principal 
Investigator: Martin Hautzinger, PhD); 2) Department of Psychiatry, University of 
Heidelberg (Site Principal Investigator: Matthias Backenstraß, PhD); 3) Central 
Institute of Mental Health in Mannheim (Site Principal Investigator: Josef Bailer, 
PhD); 4) Psychological Outpatient Clinic, University of Marburg, (Site Principal 
Investigator: Katrin Wambach, PhD); 5) Department of Psychiatry and 
Psychotherapy, University of Luebeck, Germany (Site Principal Investigator: Philipp 
Klein, MD); 6) Department of Psychiatry; University Medical Center Bonn (Site 
Principal Investigator: Dieter Schoepf, MD); 7) Department of Psychosomatic 
Medicine and Psychotherapy, University Medical Center Hamburg-Eppendorf and 
Clinic Center Eilbek (Site Principal Investigator: Bernd Löwe, MD); 8) Department of 
Psychiatry and Psychotherapy, University Medical Center Freiburg (Site Principal 
Investigator: Elisabeth Schramm, PhD); (9) Institute of Clinical Psychology, Hospital 
Stuttgart (Site Principal Investigator: Matthias Backenstraß, PhD)). 268 medication 
free outpatients were randomized into receiving either CBASP or SP as the active, 
nonspecific control treatment. The RCT was registered at ClinicalTrials.gov 
(NCT00970437) and was titled “A comparison of the Cognitive Behavioural Analysis 
System of Psychotherapy against supportive psychotherapy for early onset chronic 
depression”.  
 The study intervention constituted of two treatment phases (acute and 
continuation) of either CBASP or SP. The acute treatment phase included 20 weeks 
with 24 individual therapy sessions and was followed by the continuation phase. In 
the latter, patients received 28 weeks with 8 psychotherapy sessions. Figure 5, taken 
from Schramm et al. 2011, depicts the procedures of the RCT.  
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Figure 5. Design of multicentre randomized controlled trial (reprinted from 
Schramm et al., 2011a, p. 3); CBASP: Cognitive Behavioral Analysis System of 
Psychotherapy; SP: Supportive Psychotherapy; wk: week. 
 
450 patients were screened for eligibility at the participating study sites. 
Inclusion criteria were: (i) age 18 to 65; (ii) early onset (before the age of 21) chronic 
Major Depressive Disorder (MDD), or current MDD superimposed on a pre-existing 
dysthymic disorder (“double depression”), or recurrent MDD with incomplete 
remission between episodes (as diagnosed according to the Diagnostic and 
Statistical Manual of Mental Disorders (DSM-IV; American Psychiatric American 
Psychiatric Association, 2000)); and (iii) a score of 20 or above on the 24-item 
Hamilton Rating Scale for Depression (HRSD-24; Hamilton, 1967). Patients on 
antidepressant medication were asked to discontinue the medication (at least 2 
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weeks of washout) before entering the trial. Exclusion criteria were (i) acute 
suicidality, (ii) a history of psychotic symptoms, bipolar disorder, or organic brain 
disorder, (iii) a comorbid primary diagnosis of another axis I disorder, substance use 
disorder, (iv) antisocial, schizotypal, or borderline personality disorder, (v) severe 
cognitive impairment, (vi) non-response to CBASP and/or SP in an earlier trial, (vii) 
ongoing psycho-/pharmacotherapy, and (viii) a serious medical condition. All 
participants were given information on the study and gave written informed consent 
before the study commenced. This sampling procedure resulted in 268 participants 
who were stratified by centre and randomized into either CBASP (n = 134) or SP 
(n = 134).  
CBASP and SP were conducted according to manual (Markowitz & Sacks, 
2002; McCullough, 2000) and by separate therapists (n = 81). All therapists had 
completed a 3-year psychotherapy training or were in an advanced stage of training 
and had been trained in either SP or CBASP in a 2-day workshop. Before therapy 
began, therapists had to fulfil the criteria for the mastery in CBASP or SP. Mastery 
was assessed by evaluating therapists’ performance during 2 pilot cases which were 
videotaped. During the therapy, all sessions were videotaped and supervised at 
regular intervals. Moreover, manual adherence was checked on a random basis 
(Markowitz, 2003; McCullough, 2000). 
Throughout the treatment, there were four measurement points: baseline (T0), 
week 12/session 16 (T1), week 20/session 24 (T2), and week 48/session 32 (T3). 
Diagnoses were derived at T0, T2, and T3 from the Structured Clinical Interview for 
DSM-IV (SCID-I and II) (First et al., 1997a und b). At T0, patients were asked for 
socio-demographic and medical data, for example, sex, age, medical history, and 
suicidal attempts. Outcome measures included the severity of depression, treatment 
expectation, levels of anxiety, perceived quality of life, interpersonal problems, social 
functioning, and CM. Additionally, pre/post evaluations of the depressive symptoms 
by a relative of the patient were assessed. Moreover, patients and therapists 
evaluated the perceived helping alliance after each session. All clinical ratings were 
conducted by independent evaluators who were blinded to treatment condition. For 
more details on the procedure see Schramm et al. (2011a). 
To test the specific hypotheses of this dissertation, data from screening and 
baseline (sociodemographic information, medical history, diagnoses, depressive 
symptomatology, and CM) was combined with longitudinal data from every session 
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throughout treatment (alliance ratings): Sociodemographic variables and medical 
history included sex, age, marital status, education, age of depression onset. Clinical 
diagnoses were derived from the Structured Clinical Interviews for DSM-IV (SCID I 
and II; First, Gibbon, Spitzer, Williams, & Benjamin, 1997; First, Spitzer, Gibbon, & 
Williams, 2002) and severity of depressive symptoms was quantified by the 24-item 
version of the HRSD (Hamilton, 1967). CM was measured by means of the 
Childhood Trauma Questionnaire (CTQ; Bernstein et al., 2003) and the Early Trauma 
Inventory (ETI; Bremner, Vermetten, & Mazure, 2000). The alliance was assessed by 
the German version of the Helping Alliance Questionnaire for patients and therapists 
(Bassler et al., 1995; Luborsky et al., 1996). Study 1 included data on the alliance 
(HAQ-P and HAQ-T) at the beginning of therapy, that is, session 1 (if data from 
session 1 was missing, data from session 2 or session 3 was used instead) whereas 
in Study 2, HAQ-P data from all measurement points were included in the analyses. 
Methods employed for data analyses and more details on the measurement 
instruments will be described in the respective studies.  
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5 STUDY 1: THE GERMAN VERSION OF THE HELPING ALLIANCE 
QUESTIONNAIRE: PSYCHOMETRIC PROPERTIES IN PATIENTS 
WITH PERSISTENT DEPRESSIVE DISORDER 
Eich, H. S., Kriston, L., Schramm, E., & Bailer, J. (2018). The German version of the 
helping alliance questionnaire: psychometric properties in patients with persistent 
depressive disorder. BMC Psychiatry, 18(1), 107. doi: 10.1186/s12888-018-1697-8 
Abstract 
Background: The Helping Alliance Questionnaire (HAQ) is a frequently used and 
highly relevant instrument to assess the therapeutic alliance. The questionnaire was 
translated into German by Bassler and colleagues (1995) and is available for patients 
(HAQ-P) and therapists (HAQ-T). Whereas the HAQ-P has been tested regarding 
psychometrics, the HAQ-T has not. This study aimed at further investigating the 
psychometric properties of both the HAQ-P and HAQ-T. We hypothesized that the 
instrument is reliable and shows factorial as well as convergent validity. Methods: 
Within the framework of a multisite, randomized-controlled clinical trial, comparing the 
efficacy of Cognitive Behavioral Analyses System of Psychotherapy (CBASP) and 
supportive psychotherapy (SP) in the treatment of early onset persistently depressed 
outpatients, the HAQ was filled out by patients (n=255) and therapists (n=81). 66.0% 
of patients were female; average age at randomization was 44.9 years (SD=11.8). 
Several confirmatory factor analyses were conducted to test different structures for 
the HAQ. In addition, correlations between the HAQ and the Inventory of 
Interpersonal Problems (IIP) were calculated to test for convergent validity. Results: 
Goodness of fit indices for both a model with two different but strongly related factors 
named ‘relation to the patient/therapist’ and ‘satisfaction with therapeutic outcome’ 
and a second model with only one global helping alliance factor were comparable: 
Chi-Square-based indices rejected the models; RMSEA closely approached the 
threshold of good model fit, and CFI/TLI and SRMR suggested that both models 
sufficiently fit the data. The internal consistency (Cronbach’s α) calculated for the 
different scales of the HAQ ranges between questionable to good. Finally, the HAQ 
scores were significantly related to some of the IIP scores. Conclusions: The German 
versions of the HAQ offer sufficient reliable instruments for the quick assessment of 
different facets of the therapeutic alliance. The HAQ global scores can be used as 
indicators for the global impression of the patients’ and therapists’ perception of the 
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quality of the therapeutic alliance. However, the small correlations found between the 
IIP and the HAQ puts the question of external validity into perspective.  
 
Trial registration: This study analysed data from a RCT which was registered on 
ClinicalTrials.com (NCT00970437). First submitted on September 1, 2009.  
 
Keywords: Helping alliance questionnaire (HAQ), Helping alliance, Therapeutic 
alliance, Psychometrics, Persistent depression 
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5.1 Background  
The relationship between patient and therapist is one important factor in 
psychotherapy which predicts therapy outcome (Crits-Christoph, Gibbons, & 
Mukherjee, 2013; Wampold & Imel, 2015). One perspective on this relationship is the 
concept of alliance which was originally defined by Bordin (1979) and “describes the 
degree to which the therapy dyad is engaged in collaborative, purposive work” 
(Hatcher & Barends, 2006, p.293). Today, it is the most studied process variable in 
psychotherapy research (Flückiger et al., 2015). Three internationally often used 
instruments to measure alliance are the Helping Alliance Questionnaire (Luborsky, 
2000), the Working Alliance Inventory (Horvath & Greenberg, 1989) and the 
California Psychotherapy Alliance Scales (Hatcher & Barends, 1996; Marmar, Weiss, 
& Gaston, 1989). The Working Alliance Inventory (Horvath & Greenberg, 1989) is 
directly derived from Bordin’s theory of alliance (Hatcher & Barends, 2006). It 
measures the agreement of patient and therapist on goals for and tasks in therapy as 
well as the affective bond between patient and therapist (Horvath & Greenberg, 
1989). The California Psychotherapy Alliance Scales, which incorporates several 
perspectives on alliance, assesses the (i) patient’s commitment to therapy, (ii) the 
working capacity of the patient, (iii) the therapist’s understanding and involvement 
and (iv) the agreement of patient and therapist on goals and tasks (Gaston, 1991). 
The Helping Alliance Questionnaires (HAQ), of which one was investigated in this 
study, were developed by Alexander and Luborsky (1986). The first version of the 
HAQ was designed so that it encompasses two dimensions: HA1, that is, the patient 
perceiving the therapist as helpful and supportive and HA2, that is, working together 
towards common goals. Despite the two dimensions, authors themselves worked 
with the sum score of all items (Luborsky et al., 1985). Later, Luborsky and 
colleagues developed a revised version of the HAQ, the HAq-II, in which the authors 
removed 6 items on early symptomatic improvement and added 14 items on the 
collaboration between patient and therapist, on how the patient perceived the 
therapist and on how the patients perceives the therapist’s feeling toward him or her 
(Luborsky et al., 1996). The revised version however lacks sound psychometric 
testing and application in research (Nübling et al., 2017). Hence, while there is the 
HAq-II (for patients, therapists and observers), the HAQ is still widely used and 
recommended for research (Elvins & Green, 2008; Martin et al., 2000). The factor 
structure and psychometric properties of the HAQ have been investigated in six 
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studies, which included in- and outpatient samples with heterogeneous diagnoses 
and receiving different forms of psychotherapy (Bassler & Nübling, 2015; Bassler et 
al., 1995; De Weert-Van Oene, Jorg, & de Jong, 2006; Hatcher & Barends, 1996; 
Hendriksen et al., 2010; Nübling et al., 2017). The studies generally confirmed the 
HAQ’s quality and its two factors: one related to the relationship and the other to 
outcome. Yet, the assignment of items to factors as well as the labelling of factors 
differed between studies. The authors attributed these discrepancies to differing 
statistical approaches (e.g., relying solely on exploratory factor analysis or allowing 
for correlated errors in confirmatory factor analysis), linguistic, cultural and scaling 
influences on responses, as well as differences in study setting such as study sample 
and treatment (Bassler & Nübling, 2015; Bassler et al., 1995; De Weert-Van Oene et 
al., 2006; Hatcher & Barends, 1996; Hendriksen et al., 2010; Nübling et al., 2017). 
5.1.1 German version of the HAQ  
5.1.1.1 Factor structure 
Only the first version of the HAQ was translated into German (Bassler et al., 1995). 
Like Alexander and Luborsky (1986), the German authors found two factors (Bassler 
& Nübling, 2015; Bassler et al., 1995). Yet, the assignment of items to factors and the 
number of items per factor differed to the originally proposed two-dimensional 
structure by Alexander and Luborsky (1986) (Elvins & Green, 2008; Martin et al., 
2000). Two studies explicitly investigated the factor structure of the German version 
of the HAQ which is available in two versions – one for the patient (HAQ-P) and one 
for the therapist (HAQ-T). The earlier study (Bassler et al., 1995) tested the HAQ-P in 
a sample of 239 psychodynamically treated inpatients with diverse diagnoses and 
found two factors, which they called ‘satisfaction with therapeutic outcome’ (items 2, 
3, 4, 5, 11) and ‘relation to the therapist’ (items 1, 6, 7, 8, 9, 10). Item 2 and item 3 did 
not load clearly on either factor. Based on the items’ semantics, the authors assigned 
these items to the factor labelled ‘satisfaction with therapeutic outcome’. This 
assignment was later confirmed by test theoretical examination. Cronbach’s α of the 
global alliance scale was 0.89; the internal reliability of the subscales was similarly 
high (‘relation to the therapist’: Cronbach’s α = 0.89, ‘satisfaction with therapeutic 
outcome’: Cronbach’s α = 0.84). The intercorrelation between the factors was 
r = 0.43. Recently, a study by Nübling et al. (2017) generally supported the two-
factorial structure in a combined sample of three studies with in total 4626 in- and 
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outpatients. Yet, items 1, 2 and 3 loaded inconsistently on the factors. Moreover, the 
fit indices of the confirmatory factor analyses suggested that the two items should be 
removed from the questionnaire. The authors however retained the two-dimensional 
structure of the HAQ-P including all 11 items for content-related reasons and 
because it is commonly used. The factors correlated between r = 0.45 and r = 0.76. 
Hence, considering the equivocal findings with regards to the factor structure of the 
HAQ, the call for a sound psychometric foundation of the widely used HAQ-P 
(Nübling et al., 2017) and its appropriateness to measure the helping alliance 
(Puschner et al., 2005) remains open to discussion. Furthermore, psychometric 
examination of the German HAQ-T is entirely lacking. Therefore, this study aimed at 
adding to the already existing literature by testing the reliability and the factorial 
structure, of the German version of the HAQ-P and HAQ-T. 
5.1.1.2 Validity 
The German HAQ-P was found to have satisfactory convergent and discriminant 
validity as assessed by a number of variables which directly or indirectly measure 
therapy outcome and motivation for therapy (Bassler & Nübling, 2015; Bassler et al., 
1995; Nübling et al., 2017). We sought to expand the research on the validity of the 
HAQ by correlating the HAQ-P and HAQ-T with patients’ pre-treatment interpersonal 
problems. Patients with friendly-submissive behaviours facilitate a positive alliance 
with the therapist, whereas patients with hostile-dominant behaviours negatively 
impact alliance (Muran, Segal, Samstag, & Crawford, 1994). Also, McCullough 
(2000) postulates that the hostile and hostile-submissive behaviours of persistently 
depressed patients impedes the interactions between patient and therapist. Hence, 
alliance scores should be negatively related to patients being overly hostile-
dominant, hostile and hostile-submissive. Patients being friendly-submissive should 
be positively related to alliances scores. 
5.1.1.3 Hypotheses 
We hypothesised that the two theoretically proposed factors, that is, ‘satisfaction with 
therapeutic outcome’ and ‘relation to the patient/therapist’, would be confirmed and 
that the resulting subscales would be reliable and convergently valid. 
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5.2 Methods  
The hypotheses were tested with data from a randomized controlled trial (RCT) 
comparing the efficacy of the Cognitive Behavioural Analysis System of 
Psychotherapy (CBASP) to an active control group, that is, supportive psychotherapy 
(SP). The RCT was registered on ClinicalTrials.com (NCT00970437). This 
prospective and observer-blind study was conducted at eight university centres 
throughout Germany. For details on the procedures, methodology, and outcome of 
the RCT see (Schramm, 2015; Schramm et al., 2017). 
5.2.1 Participants  
Patients between the age of 18 and 65 years, who had been diagnosed according to 
the Diagnostic and Statistical Manual of Mental Disorders (DSM-IV; American 
Psychiatric Association, 2000) with an early onset (before the age of 21) diagnosis of 
chronic Major Depressive Disorder (MDD), current MDD superimposed on a pre-
existing dysthymic disorder (“double depression”) or recurrent MDD with incomplete 
remission between episodes and scoring a minimum of 20 points on the 24-item 
Hamilton Rating Scale for Depression (HRSD; Hamilton, 1967) were eligible to 
participate. Patients on antidepressant medication had the opportunity to discontinue 
it (at least two weeks of washout) before entering the trial. Unless any of the following 
exclusion criteria were met, patients were invited to take part in the study. Exclusion 
criteria were (i) acute suicidality, (ii) a history of psychotic symptoms, bipolar disorder, 
or organic brain disorder, (iii) a comorbid primary diagnosis of another axis I disorder, 
substance use disorder, (iv) antisocial, schizotypal, or borderline personality disorder, 
(v) severe cognitive impairment, (vi) non-response to CBASP and/or (SP) in an 
earlier trial, (vii) ongoing psycho −/pharmacotherapy, and (viii) a serious medical 
condition (Schramm, 2015). This sampling procedure resulted in 268 participants of 
whom 66% were female and who were on average 44.91 (SD = 11.82) years old 
(Table 1). 
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Table 1 
Patient characteristics at baseline  
Variable 
Participants 
(n = 268) 
Age, M, SD 44.91; 11.82 
Gender, n (%)  
Male 91 (34.0) 
Female 177 (66.0) 
Age at onset, M; SD 13.00; 4.41 
Marital status, n (%)  
Married; cohabiting 106 (39.6) 
Single 117 (43.7) 
Divorced, widowed 45 (16.8) 
Educational level, n (%)  
≤ 11 years 96 (35.8) 
≥ 12 years 172 (64.2) 
Diagnosisa, n (%)  
Double Depression 119 (45.8) 
Chronic Major Depression 82 (31.5) 
Recurrent Major Depression without complete remission 
between episodes 
59 (22.7) 
Early traumaa, b, n (%)  194; 74.6 
CTQ global sum scorea, M; SD 52.82; 16.03 
Emotional abusea, M; SD 13.82; 5.57 
Physical abusea, M; SD 7.83; 4.21 
Sexual abused, M; SD 6.52; 3.03 
Emotional neglecte, M; SD 16.18; 5.02 
Physical neglecta, M; SD 8.43; 3.17 
HRSD scorec, M; SD 27.07; 5.61 
Notes. a n = 260 (different to Schramm et al. (2017), we included belatedly collected 
(session 3) CTQ data for 4 participants for whom data was missing at baseline); b at 
least moderate to severe in 1 of 5 dimensions assessed with the Childhood Trauma 
Questionnaire; c HRSD = Hamilton Rating Scale of Depression; d n = 258, e n = 259. 
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5.2.2 Treatments  
Psychotherapy ran in parallel in both conditions (CBASP and SP) and included an 
acute therapy phase (20 weeks, 24 individual sessions) followed by eight 
continuation sessions over the next 28 weeks. CBASP is a highly structured 
intervention in which patients learn to recognize the effects of their behaviours on 
others, to actively deal with interpersonal problems and to strengthen self-efficacy by 
reaching their desired outcomes with other people. SP is a supportive, nonspecific, 
client-centred approach to psychotherapy including elements of psychoeducation and 
facilitation of affect (Markowitz, Manber, & Rosen, 2008). 
5.2.3 Therapists  
CBASP and SP were conducted by two groups of psychotherapists (n = 81), all of 
whom had either completed a three-year psychotherapy training or were in an 
advanced stage of training. In addition, therapists had been trained in a two-day 
workshop and had at least one practice day in either CBASP or SP. Before therapists 
began working with patients, they had to meet the criteria for mastery in CBASP or 
SP. During the therapy, all sessions were videotaped, and supervision took place 
regularly. 
5.2.4 Measures  
5.2.4.1 Demographic variables and early maltreatment  
During the initial screening, sociodemographic variables, such as sex, age, 
nationality, marital status, education, occupation, and employment were recorded. 
Additionally, the Childhood Trauma Questionnaire (CTQ; Bernstein et al., 2003) was 
used to assess early traumatization in terms of emotional and physical abuse or 
neglect and sexual violence. 
5.2.4.2 Diagnoses and depressive symptomatology  
Before therapy commenced, clinical diagnoses had been derived from the Structured 
Clinical Interviews for DSM-IV (SCID I and II; First et al., 1997; First et al., 2002) and 
severity of depressive symptoms had been quantified by the 24-item version of the 
HRSD. 
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5.2.4.3 Therapeutic alliance  
Alliance was assessed at the beginning of therapy, that is, after session 1. If the 
alliance questionnaire was not distributed and/or was not returned after session 1, 
alliance was assessed after session 2 or 3. Both patient and therapist filled out the 
HAQ-P and HAQ-T (Bassler et al., 1995), respectively. The 11 items of these self-
report instruments take maximally 10 min to fill out. All items were rated on a 6-point 
Likert Scale from “strongly agree” (3 points) to “strongly disagree” (−3 points). 
5.2.4.4 Pretreatment interpersonal problems  
We measured interpersonal problems by means of the German version of the 
Inventory of Interpersonal Problems (IIP-64; Horowitz, Alden, Kordy, & Strauß, 2000). 
Its 64 items (5-point Likert scale) assess several aspects of social malfunctioning on 
8 subscales which are correlated in the form of a circumplex: (i) 
domineering/controlling, (ii) vindictive/self-centred, (iii) cold/distant, (iv) socially 
inhibited, (v) non-assertive, (vi) overly accommodating, (vii) self-sacrificing, (viii) 
intrusive/needy. The subscales 1 through 4 describe problems with being too 
dominant, hostile, hostile-dominant, and hostile-submissive. The other subscales 
deal with problems concerning friendly submissiveness or friendly dominance. The 
questionnaire has been found to be a reliable and valid research instrument in 
English and German populations (Horowitz et al., 2000). 
5.2.5 Data analysis  
To test the factor structure of the German HAQ for patients and therapists, we 
performed confirmatory factor analyses (CFA) by means of structural equation 
modelling with diagonally weighted least squares estimation (WLSMV). In the 
analyses items were modelled as ordinally scaled. Based on the recommendation to 
consider several tests when evaluating model fit (Chen, Curran, Bollen, Kirby, & 
Paxton, 2008), we included the following indices: Normed Chi-Square (Chi-Square 
Test of Model Fit divided by Degrees of Freedom), Root Mean Square Error of 
Approximation (RMSEA), Comparative Fit Index (CFI), Tucker Lewis Index (TLI) and 
the Standardized Root Mean Square Residual (SRMR). In order to interpret the fit 
indices we relied on the same cut-off values (Table 3) as Nübling et al. (2017) did in 
their study on the HAQ. The models were investigated with regards to internal 
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consistency and external validity. The internal consistency of the HAQ was assessed 
by use of Cronbach’s α. To externally validate the German HAQ as a measure to 
assess the therapeutic alliance between patient and therapist, we performed Pearson 
correlations (two-tailed) between HAQ and IIP (total score and subscale scores). All 
descriptive statistics, analyses on internal consistency and external validation were 
performed using IBM SPSS Statistics 24 (SPSS Inc., 2015); lavaan for R (Rosseel, 
2012) was used to perform the CFA. 
5.3 Results  
The sample comprised of 268 patients (Table 1), 177 (66.0%) of whom were female, 
with an average age of 44.91 (SD = 11.82). Almost half of the sample was suffering 
from double depression (45.8%). The other patients had either chronic major 
depression (31.5%) or recurrent major depression without complete remission 
between episodes (22.7%). Patients reported a mean age of onset of 13 years 
(SD = 4.41). The average HRSD score at baseline was 27.07 (SD = 5.61). Most 
patients were single (43.7%) or married (39.6%), 16.8% were divorced or widowed. 
About one third (35.8%) of patients had been in formal education for at least 12 
years. Over 70% reported early childhood maltreatment. Of the 255 patients, who 
returned the HAQ-P, 254 also filled out the IIP. 
5.3.1 Confirmatory factor analysis and internal consistency  
To confirm the postulated two-dimensional factor structure of the HAQ (Bassler & 
Nübling, 2015; Nübling et al., 2017), we assumed a model with two latent factors in 
confirmatory factor analysis. This model was tested for both the patient and the 
therapist versions of the questionnaire. Structural equation modelling showed that 6 
relationship items and 5 outcome items correlated significantly with the latent factors 
(Table 2) and that the two factors strongly correlated (HAQ-P: r = .83; HAQ-T: 
r = .88). While the goodness of fit indices were mostly satisfactory for the HAQ-T 
(χ2 = 153.98, df = 43, p < .001, χ2/df = 3.58, RMSEA = .10, CFI = .98; TLI = .97, 
SRMR = .08), the indices were inconclusive for the HAQ-P (χ2 = 213.36, df = 43, 
p < .001, χ2/df = 4.96, RMSEA = .12, CFI = .98; TLI = .98, SRMR = .07) (Table 3). 
Cronbach’s α of the two scales ranged from .89 to .75 on the HAQ-P and from .85 to 
.63 on the HAQ-T. Because of the high correlation between the factors and cross-
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loadings between items and factors, we tested a competing one-factor model (Table 
2).  
Table 2 
Standardized factor loadings of items on factors for a two- and one-factorial model 
 2 factors 1 factor 
HAQ-Pa 
Relation to the 
patient/therapist 
Satisfaction 
with 
therapeutic 
outcome 
Helping 
alliance 
1: I believe that my therapist is helping 
me. 
.91c  .88c 
6: I feel I can depend on my therapist. .75**  .74** 
7: I feel the therapist understand me. .78**  .77** 
8: I feel the therapist wants me to 
achieve my goals. 
.84**  .83** 
9: I feel I am working together with the 
therapist in a joint effort. 
.88**  .87** 
10: I believe we have similar ideas 
about the nature of my problems. 
.73**  .72** 
2: I believe that the treatment is helping 
me.  
.95c .85** 
3: I have obtained some new 
understanding. 
 .69** .64** 
4: I have been feeling better recently.  .65** .62** 
5: I can already see that I will eventually 
work out the problems I came to 
treatment for. 
 .76** .70** 
11: I feel now that I can understand 
myself and deal with myself on my own. 
 .22** .21** 
    
Correlation between factors .83**  
M; SD 1.56; 0.84 -0.06; 1.15 0.82; 0.88 
Cronbach’s α .89 .75 .87 
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HAQ-Tb    
1: I believe that I am helping my patient. .77c  .76 c 
6: I feel that my patient relies on me. .66**  .66** 
7: I feel that my patient feels 
understood. 
.87**  .86** 
8: I feel my patient believes I am 
committed to the attainment of his/her 
goals.  
.91**  .90** 
9: I feel that my patient is working 
together with me in a joint effort. 
.79**  .78** 
10: I believe my patient and I have 
similar ideas about the nature of his/her 
problems. 
.69**  .69** 
2: I believe that the treatment is helping 
my patient. 
 .77c .71** 
3: I believe that my patient has obtained 
some new understanding. 
 .71** .66** 
4: I believe that my patient has recently 
been feeling better.  
 .32** .30** 
5: I believe my patient will eventually 
work out the problems he/she came to 
treatment with. 
 .57** .53** 
11: I feel now that my patient can 
understand him/herself and can deal 
with him/herself on his/her own. 
 .28** .26** 
    
Correlation between factors .88**  
M; SD 0.91; 0.80 -0.32; 0.83 0.35; 0.72 
Cronbach’s α .85 .63 .84 
Note. a n = 255; b n = 260; ** p < .001; * p < .05; c reference item in the model; HAQ-
P = Helping Alliance Questionnaire for patients; HAQ-T = Helping Alliance 
Questionnaire for Therapists. 
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In the one-factor model all items load onto one latent global factor. This model had 
comparable or slightly inferior fit indices than the two-factor model: HAQ-P 
(χ2 = 268.42, df = 44, p < .001, χ2/df = 6.10, RMSEA = .14, CFI = .98; TLI = .97, 
SRMR = .09) and HAQ-T (χ2 = 163.95, df = 44, p < .001, χ2/df = 3.73, RMSEA = .10, 
CFI = .98; TLI = .97, SRMR = .08) (Table 3). Cronbach’s α of the global scale was 
.87 for the HAQ-P and .84 for the HAQ-T. 
Table 3 
Goodness of fit indices for a two- and one-factorial model 
Model χ2 df p χ2/df RMSEA CFI/TLI SRMR 
Two-factorial model        
HAQ-P 213.36 43 < .001 4.96 .12 .98/.98 .07 
HAQ-T 153.98 43 < .001 3.58 .10 .98/.97 .08 
One-factorial model        
HAQ-P 268.42 44 < .001 6.10 .14 .98/.97 .09 
HAQ-T 163.95 44 < .001 3.73 .10 .98/.97 .08 
        
Cut-off    > .05 < 3 ≤.10 ≥ .95/≥ .90 < .11 
Note. df = degrees of freedom; RMSEA = root mean error of approximation; 
CFI = comparative fit index; TLI = Tucker Lewis index; SRMR = standardized root 
mean square residual; HAQ-P = Helping Alliance Questionnaire for Patients; HAQ-
T = Helping Alliance Questionnaire for Therapists. 
5.3.2 External validity  
Table 4 shows the correlations between the HAQ global alliance score and its 
subscales with the IIP total score and its subscales. 
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Table 4 
Correlations between the HAQ and the IIP total score and its 8 subscales 
 
HAQ-Pb  HAQ-Tc 
 
 Relation to the 
patient/therapist 
Satisfaction with 
therapeutic 
outcome 
Helping 
alliance 
 Relation to the 
patient/therapist 
Satisfaction with 
therapeutic 
outcome 
Helping 
alliance 
IIPa M; SD r r r  r r r 
total score 14.92; 3.69 -0.10 -0.15* -0.14*  -0.05 -0.05 -0.06 
Domineering/controlling 8.31; 5.10 -0.14* -0.10 -0.13*  -0.12 -0.12 -0.13* 
Vindictive/self-centred 11.02; 5.19 -0.17** -0.18** -0.19**  -0.11 -0.11 -0.12 
Cold/distant 14.79; 6.04 -0.21* -0.21** -0.23**  -0.08 -0.08 -0.09 
Socially inhibited 17.93; 6.71 -0.16* -0.23** -0.22**  -0.11 -0.11 -0.12* 
Non-assertive 20.04; 6.68 -0.03 -0.12 -0.08  0.00 0.01 0.01 
Overly accommodating 17.49; 5.83 0.07 -0.00 0.03  0.10 0.10 0.11 
Self-sacrificing 18.71; 5.29 0.11 -0.01 0.06  0.08 0.08 0.09 
Intrusive/needy 11.10; 5.33 0.05 -0.09 0.08  -0.01 -0.02 -0.02 
Note. a n = 254; b n = 255; c n = 260; ** p < .01, *p < .05; HAQ-P = Helping Alliance Questionnaire for Patients, HAQ-T = Helping 
Alliance Questionnaire for Therapists; IIP = Inventory of Interpersonal Problems.
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5.3.3 HAQ-P  
The IIP total score correlated significantly negatively with the HAQ-P global helping alliance 
score (r = −0.14, p = .03) and with the subscale ‘satisfaction with therapeutic outcome’: 
r = −0.15, p = .02). The HAQ-P global score also had a significant negative relationship with 
the following interpersonal problems: domineering/controlling (r = −0.13, p = .04), 
vindictive/self-centred (r = −0.19, p < .01), cold/distant (r = −0.23, p < .01), and socially 
inhibited (r = −0.22, p < .01). Likewise, the subscale ‘relation to the therapist’ was negatively 
correlated with the same octants: domineering/controlling (r = −0.14, p = .03), vindictive/self-
centred (r = −0.17, p = .01), cold/distant (r = −0.21, p < .01), and socially inhibited 
(r = −0.16, p = .01). The HAQ-P subscale ‘satisfaction with therapeutic outcome’ was only 
related to the following IIP subscales: vindictive/self-centred (r = −0.18, p < .01), cold/distant 
(r = −0.21, p < .01), and socially inhibited (r = −0.23, p < .01). 
5.3.4 HAQ-T  
For the HAQ-T, significant correlations were found between the helping alliance global scale 
and the octants domineering/controlling (r = −0.13, p = .03) and socially inhibited (r = −0.12, 
p = .04). 
5.4 Discussion  
We examined the psychometric properties of the German HAQ in a large sample of early-
onset persistently depressed outpatients and their therapists. By means of structural 
equation modelling we sought to confirm the elsewhere (Nübling et al., 2017) assumed two-
factorial structure of the HAQ. Fit indices were heterogeneous: Chi-Square-based indices 
rejected the model; RMSEA closely approached the threshold of good model fit, and 
CFI/TLI and SRMR suggested that this two-factorial model sufficiently fit the data. Because 
of the ambiguous fit indices, items cross loading on factors and the high correlation between 
the factors (HAQ-P: r = .83; HAQ-T: r = .88), we ran additional CFA on a competing one-
factor model. The second analysis showed that a one-factorial model had a mostly 
comparable model fit. Standardized loadings of items on latent factors were generally high. 
Only item 11 (HAQ-P: “I feel now that I can understand myself and deal with myself on my 
own.”, HAQ-T: “I feel now that my patient can understand him/herself and can deal with 
him/herself on his/her own.”) had consistent loadings of < .30 onto the factor ‘satisfaction 
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with therapeutic outcome’ in the two-factorial model and on the global factor in the one-
factorial model. This may be due to the fact that data was collected at the very beginning of 
treatment when agreeing to this item is unlikely. Other items can be agreed on earlier in the 
process of therapy. We expect that at a later point in the treatment, item 11 will load onto 
the factor labelled ‘satisfaction with therapeutic outcome‘, which it has been assigned to 
mainly for content-related reasons. 
Generally, our findings mirror that of other studies on the psychometric properties of 
the HAQ: the HAQ, that is, its global scale and its subscales are internally consistent. Like 
in other studies, we found very high correlation between the latent factors, which indicates 
how close, the dimensions ‘relation to the therapist/patient’ and ‘satisfaction with therapeutic 
outcome’ are. While the intercorrelation between the latent factors parallels earlier findings, 
the magnitude of the herein reported correlation may have been overestimated due to using 
WLSMV estimation in a small sample (Li, 2016). 
Like in other studies which employed CFA to verify a theoretically proposed factor 
structure (Muncer & Campbell, 2004), our results failed to unambiguously confirm the HAQ 
scale(s). Our findings are partially in line with Nübling et al. (2017): they, too, found flaws in 
the two-factorial structure. In their analyses a two-factorial model without item 2 and 3 
proved superior to the proposed model. Because of content related reasons and due to the 
dispersion of the two-factor solution which includes all 11 items, the authors retained the 
unsatisfactory yet well-known model. No other German study has sought to confirm a one 
factor structure of the HAQ.  
Previous research on the Dutch HAQ (Hendriksen et al., 2010), too, compared the fit 
of a two- and a one-factor model of the HAQ and also found items cross-loading (two-
factorial model) and correlated measurement errors in the models. Moreover, they had 
slightly inferior fit indices for the one- than for the two-factorial model, which is why they 
retained the two-factorial model.  
In the literature the HAQ is used uni- and two-dimensionally. Our findings from CFA 
suggest that the model fit of a two- and one-factorial model is largely comparable. Hence, 
two models reasonably fit the data. Like in other herein cited studies, model fit was not 
persistently conclusive, but acceptable with regards to CFI, TLI, and SRMR. The finding that 
the fit indices are inconclusive is unfortunate but not surprising as they are differently 
susceptible to aspects of structural equation modelling (e.g., Fan, Thompson, & Wang, 
1999). 
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It is known that most fit indices can be affected by sample size, but also by 
estimation method and other aspects (Fan et al., 1999; Marsh, Balla, & McDonald, 1988). 
One study employed Maximum Likelihood (ML) and Generalized Least Squares (GLS) 
estimation and found that in comparison to other indices RMSEA and CFI were minimally 
influenced by sample size (Fan et al., 1999). Regarding the herein employed diagonally 
weighted least squares estimation (WLSMV) method, there is, to our knowledge, no 
consensus as to how sample size affects the resulting fit indices. Rather, the WLSMV 
estimator has not been studied sufficiently yet (Beauducel & Herzberg, 2006). Two studies 
investigating the effect of sample size on WLSMV estimation found that WLSMV performs 
equally well as ML across different sample sizes (Beauducel & Herzberg, 2006). Another 
study (Li, 2016) however found that in small samples (i.e., n = 200) models based on 
WLSMV tend to be over rejected by the Chi-Square Test. Therefore, the common 
assumption that Chi-Square based fit indices are lenient in small samples (Fan et al., 1999) 
may not hold true for our study. Rather, the unsatisfactory Chi-Square results in our study 
may be due to having relied on WLSMV estimation in a relatively small sample. 
In light of the herein used methods and the results, looking at the global alliance 
scale or the subscales of the HAQ is both equally feasible. Therefore, the researcher or 
clinician will have to decide what approach better fits the purpose. Working with a two-
factorial model holds the advantage of comparability: the subscales are well known and 
commonly used. Moreover, items on the scale ‘satisfaction with therapeutic outcome’ are 
confounded with therapy outcome (Nübling et al., 2017). Therefore, assessing alliance on 
both subscales allows a more fine graded disentanglement of process and outcome 
variables in psychotherapy research. On the other hand, assessing alliance on one global 
score is arguably very economic. What is more, relying on one global HAQ score is 
frequently done (e.g., Constantino & Smith-Hansen, 2008). 
Previously, validity of the German HAQ-P had been established through symptom-, 
treatment-, and health related instruments (Nübling et al., 2017). To our knowledge, this is 
the first study, which used a measure of interpersonal problems to validate both versions of 
the HAQ in a sample of persistently depressed patients. We found that patients’ ratings of 
the global helping alliance were significantly and negatively related to a sum score of 
interpersonal problems. This means that the more interpersonal problems a patient had 
before therapy, the more negative was the evaluation of the helping alliance. Additionally, 
we found that the more severe problems a patient had with being too dominant, too hostile 
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or too hostile-submissive (i.e., subscales domineering/controlling, vindictive/self-centred, 
cold/distant, socially inhibited), the more negative the patient perceived the global alliance. 
These results are in line with research that found that being too hostile (Puschner et al., 
2005) or too hostile-dominant (Connolly Gibbons et al., 2003) negatively impacts the 
helping alliance at treatment begin. What is more, our finding that patients who are too 
hostile-submissive evaluate the alliance with the therapist more negatively fits McCullough’s 
assumption that persistently depressed patients exhibit passive, submissive, and hostile 
behaviours towards the therapist which impedes the interaction with the therapist 
(McCullough, 2000).  
Looking at the subscales of the HAQ-P, the results are generally similar: the higher 
the interpersonal distress and the more problems a patient has with being too hostile-
dominant, hostile and hostile-submissive, the more negative the patient evaluated the 
‘satisfaction with therapeutic outcome’. Therapists’ evaluation of the global alliance 
however, was significantly related only to patients’ interpersonal problems with being too 
dominant or too hostile-submissive. These findings are principally in line with our 
expectations. Yet, just part of our hypotheses was confirmed: Only the patient rated global 
helping alliance correlated consistently with patients’ pre-treatment problems with being too 
dominant, hostile-dominant, hostile, hostile-submissive, and the total IIP score.  
For the subscales and the therapist-rated alliance the correlational matrix was not so 
consistent. Moreover, contrary to our hypothesis, we did not find any (positive) correlations 
between the HAQ and interpersonal problems relating to being overly friendly-submissive.  
One must acknowledge that the magnitude of the association between facets of the 
IIP and the HAQ is only weak (Taylor, 1990). At the same time, the association is 
comparable in size to a study by Puschner et al. (2005). Therefore, while the results are 
relevant to the important question of how interpersonal problems are related to the helping 
alliance, the IIP may not be the most suitable instrument to establish external validity of the 
HAQ. This is because one may not expect medium or high correlations. Having said that, 
correlation coefficients in our study may reflect the homogeneity of our sample (persistent 
depressive patients), which may have decreased the variance in our data.  
Our findings must be viewed considering some limitation the study holds. Firstly, we 
did not check for a socially desirable response stile, that is, evaluating the alliance more 
positive than actually perceived, of neither patients nor therapists. In addition to that, not 
taking into account the hierarchical structure of the data (i.e., several patients were treated 
Study 1: The German version of the Helping Alliance Questionnaire: psychometric properties in patients with 
persistent depressive disorder 
 
60 
by the same therapist) is a drawback: Theoretically, it is possible that the alliance construct 
is unidimensional on one level, but two-dimensional on the other level. Differences between 
our results and those in other studies may also be accounted for by the hierarchical 
structure. Yet, the relatively big sample size and the multicentre approach of the study 
support the generalizability of the results. To the best of our knowledge, this was the first 
study to run confirmative factor analyses on both versions of the German HAQ and to 
employ a measure of patients’ pre-treatment interpersonal problems as a criterion for 
convergent validity. 
5.5 Conclusion  
The HAQ is a reliable instrument. CFA did not clearly recommend a two-factorial model 
over a one-factorial model or vice versa. Thus, our findings suggest using the instrument 
uni- or two-dimensionally, that is, to work with the global alliance scale or the subscales 
‘relation to the therapist/patient’ and ‘satisfaction with therapeutic outcome’. Patients’ and 
therapists’ perception of the alliance is related to pre-treatment interpersonal problems of 
the patient. These findings are particularly relevant to research on and with the HAQ as it is 
a standard, perhaps most widely used instrument in current psychotherapy research (Elvins 
& Green, 2008; Wampold & Imel, 2015), especially in German speaking countries (Nübling 
et al., 2017). Moreover, our results contribute to the ongoing debate on the factor structure 
of the HAQ (e.g., Hendriksen et al., 2010; Nübling et al., 2017). In summary, the HAQ, both 
for patients and therapists, is an economically applicable research instrument. It assesses 
the therapeutic alliance via two subscales ‘relation to the therapist/patient’ and ‘satisfaction 
with therapeutic outcome’ or one global scale. Moreover, its common usage in previous 
research, its brevity, the option to use it one- or two dimensionally, and its ability to measure 
changes in alliance over time (Bassler & Nübling, 2015) make the HAQ a recommendable 
instrument. 
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6 STUDY 2: DIFFERENTIAL EFFECTS OF DISORDER-SPECIFIC VERSUS 
NONSPECIFIC PSYCHOTHERAPY FOR PERSISTENT DEPRESSION 
ON THE THERAPEUTIC ALLIANCE  
Eich, H. S., Kriston, L., Schramm, E., Rief, W., Stenzel, N., & Bailer, J. Differential Effects of 
Disorder-Specific versus Nonspecific Psychotherapy for Persistent Depression on the 
Therapeutic Alliance. Submitted to Frontiers in Psychology. 
Abstract 
Objective: McCullough’s Cognitive Behavioral Analysis System of Psychotherapy (CBASP) 
was developed to help persistently depressed patients to improve on interpersonal 
difficulties rooted in childhood maltreatment (CM). These interpersonal problems also arise 
in the relationship between patient and therapist, herein referred to as therapeutic alliance, 
which is at the core to therapy with CBASP. We hypothesized that (1) CBASP has a more 
positive effect on the overall mean ratings of the therapeutic alliance than supportive 
psychotherapy (SP), that (2) alliance increases over the course of therapy with CBASP and 
SP, and that (3) this increase is most pronounced in patients with severe CM receiving 
CBASP. Method: In a multisite randomized-controlled clinical trial on the efficacy of CBASP 
vs. SP, patients (n = 268) were asked to fill in the Helping Alliance Questionnaire (HAQ; 2 
subscales: ‘relation to the therapist’ and ‘satisfaction with therapeutic outcome’) after each 
session. CM was measured with the Childhood Trauma Questionnaire (CTQ) at baseline. 
Based on their CTQ total score, patients were divided into low, medium and high CM 
groups. Treatments lasted 48 weeks and included 32 individual sessions à 50 minutes. We 
fitted a hierarchical linear model to test the hypotheses. Results: We found that (1) patients 
in the CBASP condition rated the alliance on both subscales more positively than patients 
receiving SP. On both subscales, (2) ratings became more favorable with time. (3) The 
differential effects of treatment group on increase in alliance ratings differed significantly 
between CM groups. This difference is primarily due to patients with high CM who receive 
CBASP rating the alliance increasingly better than high CM patients who receive SP. 
Conclusion: Our findings indicate that CBASP is more effective than SP in creating a 
positive therapeutic alliance across treatment. Moreover, CBASP has a particularly positive 
effect on the increase of ‘satisfaction with therapeutic outcome’ in the subgroup of patients 
with a history of severe CM. 
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6.1 Introduction 
Considerable evidence suggests that depressive disorders and in particular persistent forms 
of depression are linked to the experience of childhood maltreatment (CM) (Bailer et al., 
2014; Klein et al., 2015; Rehan et al., 2017; Riso et al., 2002; Spinhoven et al., 2010; 
Teicher & Samson, 2013; Wiersma et al., 2009). CM can be defined as “all forms of 
physical, and/or emotional or sexual abuse, deprivation and neglect of children or 
commercial or other exploitation resulting in harm to the child’s health, survival, 
development or dignity in the context of a relationship of responsibility, trust or power” 
(World Health Organization, 2013, p.1). It has also been shown that CM not only increases 
the risk for recurring or persistent forms of depression but that it also impedes treatment 
response and outcome (Nanni et al., 2012). 
In line with these findings, McCullough (2000) emphasized the importance of CM for 
the development of persistent depressive disorders. This type of depression lasts at least 
two years (American Psychiatric Association, 2013), is prevalent (Keller & Shapiro, 1982; 
Kessler et al., 2005; Murphy & Byrne, 2012; Satyanarayana et al., 2009), particularly 
burdensome (Holzel et al., 2011; Satyanarayana et al., 2009), and more difficult to treat 
than episodic depression (Angst et al., 2009; Cuijpers et al., 2010; Kocsis, 2003).  
According to McCullough (2000), persistently depressed patients exhibit 
characteristics which, he argues, result from CM and impede a positive, helpful therapeutic 
alliance. These characteristics include preoperational thinking (which involves egocentricity, 
a lack of empathy and responsiveness to feedback), lack of understanding how one’s own 
behavior affects others, and a submissive or hostile-submissive behavioral style. Because 
of these characteristics, McCullough (2000) argues, persistently depressed individuals 
necessitate a distinct personal therapeutic relationship with their therapist. Therefore, his 
Cognitive Behavioral Analysis System of Psychotherapy (CBASP) focusses on and works 
with the therapeutic relationship, hereafter referred to as alliance. Specific techniques in 
CBASP, such as disciplined personal involvement, including interpersonal discrimination 
exercise, contingent personal reaction, and use of Kiesler’s circumplex model are aimed at 
enabling the patient to make new relational experiences (McCullough, 2012). 
With regards to therapy outcome, studies of CBASP have been inconclusive. On the 
one hand, some studies suggested antidepressant effects (Kriston et al., 2014). CBASP 
also appears to be equally effective to medication alone and has shown to significantly 
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increase response and remission rates when combined with pharmacological treatments 
(Keller et al., 2000; Kriston et al., 2014; Schramm et al., 2015). CBASP was found to be at 
least as effective as other evidence-based treatments (Wiersma et al., 2014) and superior 
to treatment as usual (Michalak, Schultze, Heidenreich, & Schramm, 2015). CBASP was 
also more effective than nonspecific supportive psychotherapy (SP) in a recent trial 
(Schramm et al., 2017), whose data is used in the present study. Yet, the REVAMP trial 
(Research Evaluating the Value of Augmenting Medication with Psychotherapy), which 
investigated the additional effects of CBASP versus Brief Supportive Psychotherapy (BSP) 
to continued pharmacotherapy for partial and non-responders of pharmacotherapy only, 
found no differences between both psychotherapy conditions (Kocsis et al., 2009). 
In addition to these outcome studies, process research has been concerned with 
variables contributing to CBASP’s underlying assumptions. With regards to the assumed 
hostile-submissive interpersonal style, Constantino et al. (2008) found that therapists rated 
patients with persistent depression to be more hostile and less friendly-dominant than 
acutely depressed individuals. Compared to healthy controls, persistently depressed 
patients were found to be more hostile, hostile-submissive, and less friendly dominant. 
Moreover, personality disorder and negative social interactions are a risk factor for 
persistent depressive disorder (Holzel et al., 2011). In line with CBASP theory, which posits 
that the alliance is central for therapy outcome, studies found that early alliance, as rated by 
patients, predicted reduction of depressive symptoms in a sample of patients receiving 
CBASP alone or with medication even after controlling for prior improvement (Klein et al., 
2003). Similarly, after controlling for earlier reduction in depression and baseline global 
functioning, in patients treated with CBASP, alliance ratings were more strongly correlated 
with subsequent outcome ratings than in patients receiving BSP (Arnow et al., 2013). The 
latter study also found that patient rated alliance was more positive in patients receiving 
CBASP and antidepressant medication than in patients receiving supportive psychotherapy 
and antidepressants.  
The present study sought to add to the literature on CBASP and the therapeutic alliance 
by comparing patient-rated alliance between CBASP and nonspecific SP and by 
investigating the course of alliance over a 48 week long psychotherapy. As theory posits 
that CM is etiological for characteristics which impede the formation of a positive alliance, 
we also investigated if the course of alliance ratings differs not only between treatment but 
also between patients who had been differently exposed to CM. Based on the results by 
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Arnow et al. (2013), we expected that patients in the CBASP group rate the therapeutic 
alliance (averaged across all measurements) significantly more positively than patients in 
the SP group (hypothesis 1) and that ratings of the therapeutic alliance in both treatment 
conditions increase as psychotherapy progresses in time (hypothesis 2). We also 
hypothesized that the improvement of alliance during treatment is most pronounced in the 
patient group which CBASP was designed for, that is, persistently depressed patients with a 
history of severe CM (hypothesis 3).  
6.2 Methods 
6.2.1 Design 
The current study analyzed data from a clinical trial titled „A comparison of the Cognitive 
Behavioral Analysis System of Psychotherapy against supportive psychotherapy for early 
onset chronic depression“, which was registered on ClinicalTrials.com (NCT00970437). The 
prospective and observer-blind study was conducted at eight university centers throughout 
Germany. The study participants, who had been recruited primarily through private 
practitioners and outpatient centers, were randomly assigned to one of the two 
psychotherapeutic interventions without additional pharmacotherapy. For details on the 
procedures, methodology, and outcome of the original study see Schramm et al. (Schramm 
et al., 2011a; Schramm et al., 2017).  
6.2.2 Participants 
Outpatients were recruited at different sites. Inclusion criteria were: (i) age 18 to 65; (ii) early 
onset (before the age of 21) chronic Major Depressive Disorder (MDD), or current MDD 
superimposed on a pre-existing dysthymic disorder (“double depression”), or recurrent MDD 
with incomplete remission between episodes (as diagnosed according to the Diagnostic and 
Statistical Manual of Mental Disorders (DSM-IV; American Psychiatric American Psychiatric 
Association, 2000)); and (iii) a score of 20 or above on the 24-item Hamilton Rating Scale 
for Depression (HRSD-24; Hamilton, 1967). Patients on antidepressant medication had the 
opportunity to discontinue the medication (at least two weeks of washout) before entering 
the trial.  
Exclusion criteria were (i) acute suicidality, (ii) a history of psychotic symptoms, 
bipolar disorder, or organic brain disorder, (iii) a comorbid primary diagnosis of another axis 
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I disorder or substance use disorder, (iv) antisocial, schizotypal, or borderline personality 
disorder, (v) severe cognitive impairment, (vi) non-response to CBASP and/or SP in an 
earlier trial, (vii) ongoing psycho-/pharmacotherapy, and (viii) a serious medical condition 
(Schramm, 2015). This sampling procedure resulted in 268 participants (Table 1).   
6.2.3 Treatments 
Psychotherapy ran in parallel in both groups and included an acute therapy phase (20 
weeks, 24 individual sessions) followed by eight continuation sessions over the next 28 
weeks.  
6.2.3.1 Cognitive Behavioral Analysis System of Psychotherapy (CBASP) 
CBASP is a highly structured intervention in which patients learn to recognize the effects of 
their behaviors on others, to actively deal with interpersonal problems and to strengthen 
self-efficacy by reaching their desired outcomes with other people. CBASP is a 
psychotherapy specifically designed for patients with persistent depression. It explicitly 
addresses and works with the therapists´ emotional reactions to the patients´ dysfunctional 
behavior.  
6.2.3.2 Supportive Psychotherapy (SP) 
SP is a supportive, nonspecific, client-centered approach to psychotherapy including 
elements of psychoeducation and facilitation of affect (Markowitz et al., 2008). First findings 
from the superordinate study showed that CBASP is more effective in reducing depressive 
symptoms than SP (Schramm et al., 2017).  
6.2.4 Psychotherapists, supervision and protocol adherence 
CBASP and SP were conducted by two separate groups of psychotherapists (n = 81 in 
total), all of whom had either completed a three-year psychotherapy training or were in an 
advanced stage of training. In addition, therapists had been trained in a two-day workshop 
and had at least one practice day in either CBASP or SP. Therapists on average had 4.00 
(SP) to 5.45 (CBASP) years of experience in treating depression. Therapists in both 
conditions were roughly comparable with regards to age, sex, and experience (Schramm et 
al., 2017). Before therapists began working with patients, they had to meet the criteria for 
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mastery in CBASP or SP, which was assessed on specific rating scales (Markowitz, 2003; 
McCullough, 2000). During the therapy, all sessions were videotaped and supervised at 
regular intervals. Moreover, whether therapists adhered to the manualized procedures 
(Markowitz, 2003; McCullough, 2000) was checked on a random basis. 
6.2.5 Measures and procedures 
6.2.5.1 Childhood maltreatment  
CM was assessed at baseline with the short form Childhood Trauma Questionnaire (CTQ; 
Bernstein et al., 2003). The CTQ is a retrospective self-assessment instrument with 25 
items on which the frequency of exposure to CM is measured on a five-point Likert-scale. 
The items cover the dimensions of emotional abuse, physical abuse, sexual abuse, 
emotional neglect and physical neglect during childhood or adolescence. In order to validate 
self-reported CM, a second clinician-rated instrument, the Early Trauma Inventory (ETI; 
Bremner et al., 2000) was used. The ETI comprises 56 items assessing emotional, physical, 
and sexual abuse, as well as general trauma. For subsequent analyses total scale and 
subscale scores were computed for both the CTQ and the ETI.  
6.2.5.2 Therapeutic alliance  
After each therapy session, the German version of the Helping Alliance Questionnaire 
(HAQ; Bassler et al., 1995) was filled out by the patient. The HAQ for patients consists of 11 
items, which are rated on a 6-point Likert Scale from “strongly agree” (+3 points) to “strongly 
disagree” (-3 points). The HAQ measures the therapeutic alliance on two correlated 
subscales: ‘relation to the therapist’ and ‘satisfaction with therapeutic outcome’ (Bassler & 
Nübling, 2015; Nübling et al., 2017). In our sample, Cronbach’s α ranged from .89 on the 
scale ‘relation to the therapist’ to .75 on the scale ‘satisfaction with therapeutic outcome’ 
(Eich, Kriston, Schramm, & Bailer, 2018).  
6.2.5.3 Depressive symptoms  
Depression severity from before treatment begin was rated with the 24-item version of the 
Hamilton Rating Scale for Depression (HRSD-24; Hamilton, 1967). 
Study 2: Differential Effects of Disorder-Specific versus Nonspecific Psychotherapy for Persistent Depression 
on the Therapeutic Alliance 
 
75 
6.2.6 Statistical analyses 
In order to test our hypotheses, we fitted a hierarchical linear model with an autoregressive 
residual covariance structure. Tests were conducted with SPSS 24 (SPSS Inc., 2015) using 
a two-tailed α of 0.05 to indicate statistically significant results. Analyses were performed on 
the intention-to-treat (ITT) population, which included all randomized patients. We utilized 
the same model that was used in the primary efficacy analysis of the trial (Schramm et al., 
2017). Incomplete data were handled by maximum likelihood estimation, assuming that 
data were missing at random conditional on the information in the model. The model 
included treatment (CBASP vs. SP), time (natural logarithm of 32 consecutively numbered 
sessions as a continuous variable) and CM group (low vs. medium vs. high CM) main 
effects; time x treatment interaction, time x CM group interaction, treatment x CM group 
interaction, and CM group x treatment x time interaction for testing slope differences 
between treatment and CM groups; site and baseline HRSD as covariates; and a random 
intercept to model time-invariant interindividual differences between patients. In order to be 
able to illustrate the results from analyses on the ITT sample, a priori selected 
measurement points (session 1, 16, 24 and 32, which correspond to the efficacy endpoints 
in the study by Schramm et al. (2017) were used to report estimated marginal means with 
group comparisons. Cohens’s d was calculated for group comparisons by dividing the 
estimated difference of group means by the pooled observed standard deviation. As a 
sensitivity analysis, we ran the model on the per-protocol sample in order to test the 
robustness of our findings.  
6.3 Results 
6.3.1 Descriptive characteristics 
A total of 268 patients (66% females; mean age 44.91, SD = 11.82) were randomized on 
the two treatment arms (CBASP: n = 137; SP: n = 131) (Table 1). No systematic group 
differences between the treatment groups were found with regards to depression severity, 
age, or age of onset. Neither was gender, level of education, marital status, diagnostic 
category, or frequency of CM distributed unequally between the two treatment groups. A 
significant history of trauma (according to Bernstein and Fink (1998) defined by scoring at 
least “moderate to severe” in 1 of 5 dimensions assessed with the CTQ) was experienced 
Study 2: Differential Effects of Disorder-Specific versus Nonspecific Psychotherapy for Persistent Depression 
on the Therapeutic Alliance 
 
76 
by more than 70% of patients, emotional neglect (66%) and emotional abuse (59%) was 
experienced most frequently (Schramm et al., 2017). 
6.3.2 Definition of CM groups 
Following Spinhoven et al. (2010) who suggest to use the CTQ global scale to capture 
childhood maltreatment comprehensively, we built CM groups based on the continuous 
CTQ global scale. We were interested in comparing groups of patients with clearly differing 
levels of CM. In the absence of defined cut-offs for the CTQ global scale (theoretical range 
25-125), we subdivided the sample along the dispersion of the CTQ global score into tertiles 
with discriminative degrees of CM, similarly to an approach used in a previous study 
(Driessen, Schroeder, Widmann, von Schönfeld, & Schneider, 2006). This split of the 
sample into tertiles resulted in the following groups: none or low CM (n = 87; CTQ 
scores ≤ 44), medium CM (n = 88; CTQ scores ranging from 45 to 59), and high CM 
(n = 85; CTQ scores ≥ 60). The validity of the CTQ based CM groups was verified by 
analysis of variance using the ETI total score as dependent variable and correlational 
analyses. The CTQ groups differed significantly with regard to their ETI total score 
(F(2, 254) = 82.60, p < .001, partial η² = .39; low CM group M = 7.83, SD = 3.48; medium 
CM group M = 12.32, SD = 4.58; high CM group M = 16.39, SD = 4.87). Bivariate 
correlations indicated significant relationships between the ETI and CTQ total scores 
(r = .70, p < .001) as well as their corresponding subscales: physical abuse (r = .64, 
p < .001), emotional abuse (r = .69, p < .001), and sexual abuse (r = .77, p < .001). 
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Table 1 
Patient characteristics at baseline 
Variable 
Total 
(n = 268) 
CBASP 
(n = 137) 
SP 
(n = 131) 
Age, M (SD) 44.91 (11.82) 44.65 (12.06) 45.18 (11.60) 
Gender, n (%)    
Male 91 (34.0) 41 (29.9) 50 (38.2) 
Female 177 (66.0) 96 (70.1) 81 (61.8) 
Age at onset, M (SD) 13.00 (4.41) 12.96 (4.46) 13.05 (4.39) 
Marital status, n (%)    
Married; cohabiting 106 (39.6) 52 (38.0) 54 (41.2) 
Single 117 (43.7) 61 (44.5) 56 (42.7) 
Divorced, widowed 45 (16.8) 24 (17.5) 21 (16.0) 
Educational level, n (%)    
≤ 11 years 96 (35.8) 46 (33.6) 50 (38.2) 
≥ 12 years 172 (64.2) 91 (66.4) 81 (61.8) 
Diagnosisa, n (%)    
Double Depression 119 (45.8) 59 (43.7) 60 (48.0) 
Chronic Major Depression 82 (31.5) 42 (31.1) 40 (32.0) 
Recurrent Major Depression 
without complete remission between 
episodes 
59 (22.7) 34 (25.2) 25 (20.0) 
Childhood maltreatmenta, b, n (%)  194 (74.6) 97 (70.8) 97 (74.0) 
CTQ global sum scorea, M (SD) 52.22 (16.70) 53.45 (15.01) 53.81 (16.04) 
HRSD scorec, M (SD) 27.07 (5.61) 27.15 (5.49) 27.05 (5.74) 
Notes. a n = 260 (different to Schramm et al. (2017), we included belatedly collected 
(session 3) CTQ data for 4 participants for whom data was missing at baseline); b at least 
moderate to severe in 1 of 5 dimensions assessed with the Childhood Trauma 
Questionnaire; c HRSD, Hamilton Rating Scale of Depression; d n = 258, e n = 259.
Study 2: Differential Effects of Disorder-Specific versus Nonspecific Psychotherapy for Persistent Depression 
on the Therapeutic Alliance 
78 
 
6.3.3 Patients’ evaluation of the Helping Alliance – ‘relation to the therapist’ 
In the hierarchical linear analyses, we found that the evaluation of the ‘relation to the 
therapist’ had a positive slope over time (F(1, 1306.03) = 285.99, p < .001) and that patients 
receiving CBASP rated the alliance on average more positively than patients receiving SP 
(F(1, 280.02) = 4.19, p = .042). While the course of the ‘relation to the therapist’ was similar 
in both treatment groups for patients in the low CM group, the increase in satisfaction in the 
medium CM group was more pronounced in the SP group, while the increase of satisfaction 
in the high CM group was stronger for patients receiving CBASP (F(2, 1301.04) = 6.22, 
p = .002) (see Table 2 and Figure 1).  
Treatment group comparisons (see Table 2) showed that ratings on ‘relation to the 
therapist’ did not significantly differ between CBASP and SP in the low CM group at the pre-
defined measurement points (session 1: p = .184, d = 0.21; session 16: p = .488, d = 0.10; 
session 24: p = .594, d = 0.10; session 32: p = .678, d = 0.06). In the medium CM group, 
patients in the CBASP group indicated significantly better alliance after session 1 (p = .008, 
d = 0.41). At the other points in time, we did not find significant group differences (session 
16: p = .172, d = 0.23; session 24: p = .287, d = 0.15; session 32: p = .398, d = 0.14). There 
were no statistically significant differences between patients in the high CM group who 
received either CBASP or SP (session 1: p = .511, d = 0.11; session 16: p = .168, d = 0.21; 
session 24: p = .133, d = 0.26; session 32: p = .113, d = 0.32).  
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        Figure 1. Estimated marginal means on the ‘relation to the therapist’ subscale of the Helping 
Alliance Questionnaire by childhood maltreatment (CM) and treatment group 
(CBASP vs SP). 
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       Figure 2. Estimated marginal means on the ‘satisfaction with therapeutic outcome’ subscale 
of the Helping Alliance Questionnaire by childhood maltreatment (CM) and treatment group 
(CBASP vs SP). 
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Table 2 
Patients’ ratings on the Helping Alliance Questionnaire’s subscales at selected points in time (sessions 1, 16, 24 and 32) 
 ‘Relation to the therapist’   ‘Satisfaction with therapeutic outcome’ 
 CBASP SP adjusted effect estimates   CBASP SP adjusted effect estimates 
Time n M, SD n M, SD 
Mean difference 
(95% CI interval) p d 
 
 n M, SD n M, SD 
Mean difference 
(95% CI interval) p d 22 
Low CM 
S 1 37 1.72, 0.73 29 1.49, 0.68 0.18 (-0.09, 0.44)  .184   0.21   37 0.20, 1.10 29 -0.08, 0.86 0.13 (-0.27, 0.53) .526 0.13 
S 16 38 2.07, 0.86 24 2.05, 0.63 0.09 (-0.15, 0.33) .488 0.10   38 0.62, 1.18 24 0.74, 1.32 0.03 (-0.33, 0.39) .859 0.03 
S 24 34 2.38, 0.53 23 2.27, 0.38 0.07 (-0.17, 0.31) .594 0.10   34 0.93, 1.14 23 1.09, 1.07 0.01 (-0.36, 0.38) .946 0.01 
S 32 26 2.30, 0.63 24 2.22, 0.68 0.05 (-0.19, 0.30) .678 0.06   26 1.19, 1.30 24 1.11, 1.33 -0.00 (-0.38, 0.37) .993 0.00 
Medium CM 
S 1 34 1.57, 0.88 35 1.04, 0.90 0.39 (0.10, 0.68) .008 0.41   34 -0.18, 1.21 35 -0.31, 1.30 0.30 (-0.14, 0.74) .177 0.27 
S 16 27 1.94, 0.62 29 1.65, 0.77 0.19 (-0.08, 0.47) .172 0.23   27 0.73, 1.33 29 0.03, 1.07 0.32 (-0.09, 0.73) .129 0.29 
S 24 25 1.96, 1.18 31 1.91, 0.93 0.15 (-0.13, 0.43) .287 0.15   25 0.81, 1.44 31 0.56, 1.23 0.32 (-0.10, 0.73) .131 0.28 
S 32 21 2.08, 0.86 22 2.19, 0.66 0.12 (-0.16, 0.41) .398 0.14   21 0.92, 1.59 22 0.96, 1.13 0.32 (-0.10, 0.74) .135 0.27 
High CM 
S 1 36 1.73, 1.07 27 1.69, 0.59 0.10 (-0.20, 0.41) .511 0.11   36 0.29, 1.22 27 -0.17, 1.06 0.49 (0.04, 0.95) .034 0.46 
S 16 29 2.14, 0.99 26 2.04, 0.77 0.20 (-0.09, 0.49) .168 0.21   29 0.92, 1.22 26 0.64, 1.09 0.77 (0.35, 1.20) .000 0.72 
S 24 28 2.18, 0.73 30 1.91, 0.78 0.23 (-0.07, 0.52) .133 0.26   28 1.15, 1.33 30 0.39, 1.32 0.83 (0.39, 1.27) .000 0.72 
S 32 23 2.54, 0.54 18 2,17, 0.59 0.24 (-0.06, 0.54) .113 0.32   23 1.86, 1.01 18 0.45, 1.32 0.87 (0.43, 1.32) .000 0.81 
Notes. CBASP = Cognitive Behavioral Analysis System of Psychotherapy; SP = Supportive Psychotherapy; CM = Childhood 
Maltreatment; d = Cohen’s d (positive values indicate superiority of CBASP) small effect: d ≥ .2, medium effect: d ≥ .5, large 
effect: d ≥.8; S = Session; session 1 corresponds to treatment onset, session 16 corresponds to week 12, session 24 
corresponds to week 20, session 32 corresponds to week 48 in Schramm et al. (2017).  
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6.3.4 Patients’ evaluation of the Helping Alliance – ‘satisfaction with therapeutic 
outcome’ 
Baseline depression severity was significantly associated with patients’ outcome 
satisfaction ratings (F(1, 238.12) = 7.65, p = .006). Generally, ratings on the 
‘satisfaction with therapeutic outcome’ increased with time (F(1, 1254.59) = 269.67, 
p  < .001) and patients in the CBASP condition rated the ‘satisfaction with therapeutic 
outcome’ on average more positively than patients in the SP condition 
(F(1, 278.19) = 10.33, p < .001). The course of the ‘satisfaction with therapeutic 
outcome’ was similar in both treatment groups for patients in the low and medium CM 
groups. Yet, in the high CM group of patients, the increase in outcome satisfaction 
was more pronounced in the group receiving CBASP than in the SP group 
(F(2, 1260.03) = 3.35, p = .035) (see Table 2 and Figure 2). 
Treatment group comparisons (see Table 2) showed that ratings on 
‘satisfaction with therapeutic outcome’ were comparable between CBASP and SP in 
the low CM group (session 1: p = .526, d = 0.13; session 16: p = .859, d = 0.03; 
session 24: p = .946, d = 0.01; session 32: p = .993, d = 0.00). In the medium CM 
group there were no statistically significant differences either (session 1: p = .177, 
d = 0.27; session 16: p = .129, d = 0.29; session 24: p = .131, d = 0.28; session 32: 
p = .135, d = 0.27). In the high CM group, patients receiving CBASP indicated 
significantly greater ‘satisfaction with therapeutic outcome’ from session 1 onwards; 
the discrepancy increased over the measurement points: (session 1: p = .034, 
d = 0.46; session 16: p < .001, d = 0.72; session 24: p  < .001, d = 0.72; session 32: 
p  < .001, d  = 0.81).  
6.3.5 Sensitivity analysis 
As reported elsewhere, 171 patients (CBASP: n = 99; SP: n = 72), completed the 
study according to protocol (Schramm et al., 2017). Conducting the above analysis 
on data of the per-protocol sample reached similar results. Patients’ ‘relation to the 
therapist’ ratings increased with time (F(1, 911.42) = 205.78, p < .001) and were 
generally more positive in the CBASP than SP group (F(1, 188.32) = 5.11, p = .025) 
(see Figure 3). The increase of ‘relation to the therapist’ was similar in both treatment 
groups for patients in the low CM group, the increase in satisfaction in the medium 
CM group was more pronounced in the SP group, while the increase of satisfaction in 
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the high CM group was stronger for patients receiving CBASP (F(2, 914.30) = 7.70, 
p  < .001).  
Patients’ ‘satisfaction with therapeutic outcome’ ratings also improved with 
time (F(1, 843.03) = 177.90, p <.001) and were generally more positive in the CBASP 
than SP group (F(1, 188.31) = 5.30, p = .022) (see Figure 3). The course of the 
‘satisfaction with therapeutic outcome’ was similar in both treatment groups for 
patients in the low and medium CM groups. In the high CM group, the increase in 
outcome satisfaction was more pronounced in the group receiving CBASP than in the 
SP group (F(2, 846.69) = 3.88, p = .021). Unlike in the ITT sample, baseline 
depression severity did not have a significant influence on the alliance ratings 
(F(1,  155.95) = 2.19, p = .141). 
Figure 3 displays the mean observed HAQ ratings on both subscales of 
patients in the per-protocol sample.  
 
 
Figure 3. Observed means on the ‘relation to the therapist’ and ‘satisfaction with 
therapeutic outcome’ subscales of the Helping Alliance Questionnaire by treatment 
group (CBASP vs SP). 
 
6.4 Discussion 
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found that patients in the CBASP condition rated the alliance on both subscales, 
averaged across treatment, significantly more positively than patients receiving SP. 
On both subscales, ratings became more favorable with time. Hence, hypotheses 1 
and 2 were supported by the data.  
The differential effects of treatment group on increase in alliance ratings 
differed significantly between CM groups. When relying on the p-values of the post-
hoc analyses it becomes apparent that the three-way interaction of treatment group x 
CM group x time on the subscale ‘relation to the therapist’, was attributable to an 
initially (session 1) more positive ratings of CBASP patients with medium CM which 
diminished over time. Hence, patients with medium CM receiving SP started off with 
lower ratings which increased to a greater degree. On the subscale ‘satisfaction with 
therapeutic outcome’, the differential effect between treatment groups could be 
explained by CBASP patients giving significantly and increasingly higher ratings than 
SP patients.  
One drawback of our analyses is that they were lacking statistical power as 
the number of patients in the three CM groups split into two treatment groups was 
relatively small. Hence, it may be instructive to evaluate between group differences 
beyond their mere statistical significance and to additionally consider effect sizes. 
This approach illustrates that for patients with low CM both treatments fare equally 
well with regards to alliance, that is, level and increase of ratings on both subscales 
are comparable between CBASP and SP. For patients with a history of medium CM, 
there is a small stable level advantage of CBASP across all of treatment regarding 
the ‘satisfaction with therapeutic outcome’ subscale. Arguably, this advantage may 
be due to patients in CBASP having the expectation that they were in the more 
effective and new disorder-specific intervention. Yet, if the level advantage of CBASP 
in the medium CM group was merely caused by expectations, this positive 
expectation should emerge in all CM groups. As clearly there is no superiority of 
CBASP in the low CM group, higher expectations alone, cannot explain the more 
favorable ratings of patients with medium CM receiving CBASP. Only in the group of 
patients with high CM did we find a level advantage for CBASP, which was 
incremental over the course of treatment on both subscales. This superiority was a 
small yet increasing effect on the subscale ‘relation to the therapist’. On the subscale 
‘satisfaction with therapeutic outcome’ the effect was initially small and became large 
towards the end of treatment.  
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Conclusions from sensitivity analyses in the per-protocol sample were similar, 
which lends support to the robustness of our findings. Hence, our results indicate that 
SP and CBASP have comparable effects on the alliance on patients with a history of 
low CM and that CBASP has a small average level advantage on the ‘satisfaction 
with therapeutic outcome’ subscale for medium CM patients. Lastly, only the group of 
patients with high CM benefitted consistently and increasingly more from treatment 
with CBASP with regards to both, the ‘relation to the therapist’ and the ‘satisfaction 
with therapeutic outcome’ subscale. 
It is interesting that baseline depression severity did not negatively impact the 
alliance in the per-protocol sample while it did in the ITT sample. This may have 
resulted from lower statistical power in the per-protocol sample. Another explanation 
may be that baseline depression severity differed between completers and non-
completers of the study. This, however, was not the case (p > .05). Future subgroup 
analyses may help to understand which third factor variables, such as interpersonal 
problems, explain the differential impact of baseline depression on alliance.  
The strengths of this randomized controlled trial’s design have been reported 
elsewhere (Schramm et al., 2017). With regards to our specific research question, 
one can add that data on alliance was collected continuously after every therapy 
session which allowed for a more fine graded analysis.  
One limitation is that from this study we cannot know how exactly CBASP, or 
which CBASP technique specifically, affects patients with high CM. Moreover, given 
that the HAQ includes items related to ‘satisfaction with therapeutic outcome’ (e.g., “I 
believe that the treatment is helping me.”), alliance ratings were arguably confounded 
by therapeutic improvement achieved. Future studies may dismantle the relation 
between alliance and outcome by employing for example cross-lagged study 
designs.  
Our study was confined to data on the patient-rated alliance. We had chosen 
to do so since CBASP theory allows to deduct specific hypotheses as to how patients 
should experience the relationship to the therapist. However, future research on the 
relationship between alliance and outcome may incorporate data from both the 
patient- and the therapist-rated alliance as was for example done in a recent study by 
Laws et al. (2017), who employed dyadic multilevel modelling and found some 
support for their hypothesis that an increasing convergence on alliance ratings of 
patient and therapist was associated with better treatment outcomes.  
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Another limitation is that we did not take into account that the patient data 
were nested by therapist. While different therapists may account for variability in 
alliance ratings (Dinger, Strack, Leichsenring, Wilmers, & Schauenburg, 2008), we 
refrained from including therapists in the model so to parallel the analyses from the 
main publication as closely as possible.  
Our results are partly in line with results by Arnow et al. (2013), who found that 
early in therapy aspects of the patient-rated working alliance which concern the 
agreement of tasks and goals, were rated more positively by patients who in addition 
to medication received CBASP than by patients receiving brief supportive 
psychotherapy. Yet, our findings contradict Arnow et al. (2013) in that in our study the 
overall mean ratings on the subscale ‘relation to the therapist’ was higher in CBASP 
than in SP. The subscale ‘relation to the therapist’ bears some resemblance to the 
bond subscale in Arnow’s study. This difference may be accountable to other and 
fewer items on the bond subscale of the short version Working Alliance 
Questionnaire (Horvath & Greenberg, 1989; Tracey & Kokotovic, 1989) used by 
Arnow et al. (2013). 
Lastly, the finding that in the subgroup of patients with a history of high CM 
CBASP has a particularly positive impact on the development of the alliance 
corresponds to the subgroup analyses by Klein et al. (2018) on the same sample. 
There, the presence of CM appeared to have a moderating effect on the superiority 
of CBASP with regards to depressive symptom change. Another study found that for 
patients with a history of CM, CBASP was more effective than antidepressants and 
that the combination of CBASP and pharmacotherapy was just slightly more 
beneficial than monotherapy when comparing symptom change relative to the first 
week of treatment (Nemeroff et al., 2003, 2005). Yet, in a smaller and underpowered 
study, medication with escitalopram led to a comparable treatment response in 
patients with CM (Bausch et al., 2017). Hence, while the question if CM can serve as 
an indicator for whether to treat persistent depression with CBASP remains 
equivocal, our findings support the notion that CBASP appears beneficial in the 
group of patients with high CM when it comes to establishing a good alliance.  
We conclude that CBASP is more effective than SP in creating a positive 
therapeutic alliance across treatment. Moreover, CBASP has a particularly positive 
effect on the increase of ‘satisfaction with therapeutic outcome’ in the subgroup of 
patients with a history of severe CM. 
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7 GENERAL DISCUSSION 
This dissertation investigated how the alliance between persistently depressed 
patients and their therapists developed over the course of a 48-week long treatment 
with either the disorder-specific CBASP or the nonspecific SP. CBASP theory 
assumes that CM is aetiological for early-onset persistent depression and leads to 
characteristics which can impede the alliance. CBASP interventions are specifically 
targeted at these characteristic features which include for example, egocentrism, lack 
of empathy, and global, prelogical reasoning. Therefore, this dissertation additionally 
tested the impact of CM on the differential effects of CBASP versus SP on the 
development of alliance over the course of the treatment. 
To this end, Study 1 examined the psychometric properties, that is, factor 
structure, internal consistency and convergent validity, of the commonly used HAQ in 
its German versions for patients (HAQ-P) and therapist (HAQ-T) (Bassler et al., 
1995). Study 2 employed the HAQ-P to explore the course of alliance over 48 weeks 
of treatment and to test if CBASP had on average a more positive effect on the 
alliance. Lastly, Study 2 investigated whether CBASP and SP had differential effects 
on the development of alliance ratings by patients with a history of low, medium and 
high CM.  
The following paragraphs are a joint discussion of both studies. To begin, the 
studies’ main results and implications will be summarized. Outlook on possible future 
research will be presented before turning to the studies’ limitations, strengths and 
final conclusions. 
7.1 Main findings 
Structural equation modelling in Study 1 arrived at comparable goodness of fit indices 
for a model with two interrelated factors (HAQ-P: r = .83; HAQ-T: r = .88) called 
‘relation to the patient/therapist’ and ‘satisfaction with therapeutic outcome’ and a 
model with one global helping alliance factor: Chi-Square-based indices and RMSEA 
rejected or only closely approached the threshold of good model fit; CFI/TLI and 
SRMR indicated that both models sufficiently fit the data. Internal consistency was 
moderate to high on both subscales and on the global helping alliance scale (HAQ-P: 
Cronbach’s α ≥ .75; HAQ-T: Cronbach’s α ≥ .63).  
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Convergent validity was examined by means of correlating the HAQ 
(subscales and global scale) with the IIP and its eight dimensions. Analyses arrived 
at small (r ≤ .30) but significant correlations between the HAQ and some dimensions 
of the measure for interpersonal problems. Patients’ ratings of the global helping 
alliance were negatively related to the IIP total score and the following dimensions: 
domineering/controlling, vindictive/self-centred, cold/distant and socially inhibited. 
Similar correlational matrices were found for the subscales. Therapists’ evaluation of 
the global alliance negatively related to the IIP dimensions domineering/controlling 
and socially inhibited.  
Therefore, the hypotheses of Study 1 could only partially be supported. The 
results indicated that the patient and therapist versions of the German HAQ (Bassler 
et al., 1995) are reliable. Yet, the factor structure remains ambiguous as fit indices 
suggested that a one- and a two-factorial model fitted the observed data comparably 
well. In addition to that, item 11 of the HAQ (HAQ-P: “I feel now that I can understand 
myself and deal with myself on my own.”, HAQ-T: “I feel now that my patient can 
understand him/herself and can deal with him/herself on his/her own.”) had very 
small loadings (< .30) on the factor ‘satisfaction with therapeutic outcome’ in the two-
factorial model and on the global factor in the one-factorial model. This specific 
psychometric shortcoming may be due to the time point the data was collected at. 
Arguably, agreeing to item 11 is easier at a later point in treatment, which may result 
in higher loadings. However, issues with the factorial quality of the HAQ have 
previously been reported in other studies, too: Findings from CFA indicated relatively 
high correlations between factors, items loading inconsistently onto factors and 
modification indices suggesting the elimination of individual items altogether. Yet, for 
content-related reasons and customariness, the authors retained the two-factorial 
model, betimes aided by application of modification indices (De Weert-Van Oene et 
al., 2006; Hendriksen et al., 2010; Nübling et al., 2017). 
 The high correlation between the latent factors reported in Study 1 may have 
been overestimated because of the estimation method employed (Li, 2016). 
However, the fact that the found correlation mirrored the intercorrelations reported in 
other studies (De Weert-Van Oene et al., 2006; Hendriksen et al., 2010; Nübling et 
al., 2017), indicates how close the dimensions ‘relation to the therapist/patient’ and 
‘satisfaction with therapeutic outcome’ are. 
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 Analyses on the convergent validity of the HAQ found correlations with some 
dimension of the IIP (r ≤ .30). Arguably, these small correlation coefficients challenge 
the HAQ in terms of validity. However, Puschner et al. (2005) found comparably 
sized correlations. Hence, an alternative explanation may be that correlations 
between the HAQ and the IIP cannot be expected to be very large. The latter 
reasoning suggests that the IIP may not be an appropriate instrument to inspect the 
convergent validity of the HAQ. This reasoning holds true as previously, the validity of 
the HAQ has been established by correlating it to other (symptom-related) measures 
(e.g., Nübling et al., 2017). 
In light of the results reported in Study 1 and elsewhere (e.g., De Weert-Van 
Oene et al., 2006; Hendriksen et al., 2010; Nübling et al., 2017), Study 2 employed 
the HAQ-P and relied on its subscales to achieve a finely graded measure of the 
alliance between patients and therapists. Findings from Study 2 confirmed the a priori 
hypotheses: In both treatment conditions, alliance developed positively over time, 
that is, the alliance ratings increased from the beginning to the end of treatment. 
Patients receiving CBASP had higher overall mean alliance ratings on both 
subscales of the HAQ than did patients who received SP. CBASP and SP had 
differential effects on the increase in alliance ratings by patients with low, medium 
and high degrees of CM. In both treatment conditions, the development of alliance 
ratings was largely similar in patients with low and medium CM. Only in the group of 
patients with high CM CBASP did have a superior effect on the increase in alliance 
over the course of treatment. This effect was more pronounced on the HAQ subscale 
‘satisfaction with therapeutic outcome’. 
 Beyond the scope of the hypotheses, there were two additional interesting 
findings: In the group of patients with medium CM, on the subscale ‘satisfaction with 
therapeutic outcome’, there was a stable small level advantage of CBASP over SP. 
In the same patient group, there was a small level advantage for CBASP on the 
subscale ‘relation to the therapist’, too. This effect however diminished by session 16 
as ratings by patients in the SP condition increased quicker and caught up with 
patients’ ratings in the CBASP condition. After session 16 there were no differences 
between the treatment conditions anymore.  
General discussion 
 
98 
7.2 Limitations 
Findings from both studies must be viewed considering some statistical, 
methodological and content- or scope-related limitations. One statistical shortcoming 
is the neglect of potential bias due to a socially desirable response style. Neither 
study considered this possible bias in patient and therapist data. In addition to that, 
both studies failed to take into account that patients’ HAQ data was nested by 
therapists. This arguably affected Study 1 with regards to the results on the factor 
structure. With regards to Study 2, this is a valid criticism, too, as therapist effects 
contribute to variance in alliance ratings (Dinger et al., 2008). The reason not to 
consider the nested structure of patients’ alliance ratings in Study 2 was, that we 
sought to parallel the hierarchical linear model of the main publication (Schramm et 
al., 2017) as closely as possible. Another drawback was that Study 2 lacked 
statistical power which may have led to non-significant results in the analyses of 
between-group differences. These power issues arose from splitting the sample into 
six relatively small groups, that is, two treatment groups (CBASP and SP) and three 
CM groups (low, medium and high CM). The main publication of the superordinate 
RCT examined effects between the two treatment groups only, which is why that 
study did not encounter power issues (Schramm et al., 2017). To circumvent type II 
error, we included effect sizes in the interpretation of the results. 
 Methodologically, one may argue that the superior effects of CBASP may be 
due to therapist allegiance, that is, the degree to which therapists identify with the 
treatment they perform. However, the superordinate RCT took several measures to 
avoid allegiance bias: Training and supervision in both treatment conditions was 
conducted by experts in the respective form of treatment. What is more, the experts 
were not involved as therapists in the study (Schramm, 2017). Lastly, the results 
themselves contradict the alleged allegiance: there is no sensible explanation for why 
allegiance should influence only the group of medium CM patients (small stable level 
advantage on ‘satisfaction with therapeutic outcome’ and small initial advantage on 
‘relation to the therapist’) and high CM patients (small but increasing effects on 
‘relation with therapist’ and small to large effects on ‘satisfaction with therapeutic 
outcome’). Surely, if allegiance did account for the effects, CBASP’s superiority 
should become apparent in the group of low CM patients, too.  
 With regards to content, Study 2 leaves several questions unanswered: Firstly, 
from the results one cannot deduct which specific interventions of CBASP lead to 
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better alliance ratings. What is more, the analyses did not incorporate data on 
treatment outcome. Hence, one cannot rule out the possibility that the increased 
alliance ratings were merely a result of the improved depression (Klein et al., 2018; 
Schramm et al., 2017). Investigating the latter point of criticism goes beyond the 
scope of this dissertation though. Possible approaches to the open research 
questions will be elaborated on later. Lastly, Study 2 was limited to patients’ 
evaluation of the alliance, as assessed by the HAQ-P. The reason for that was that 
CBASP theory allows deducting specific hypotheses on how patients perceive the 
relationship to their therapist.  
7.3 Conclusion and perspective 
Vis-à-vis its limitations, the studies show several strengths which allow drawing 
meaningful conclusions. Foremost, both studies were conducted within a relatively 
long (i.e., 48 weeks, 32 sessions), carefully planned and executed RCT. The trial 
included participants who exhibited features central to persistent depression, such as 
moderate substance abuse, CM and persistent suicidality (Schramm, 2015; 
Schramm et al., 2017) In addition to that, Study 1 was the first examination of the 
German HAQ-P and HAQ-T in a sample of persistently depressed patients with 
regard to its psychometric qualities. Regarding Study 2, one must point out that to our 
knowledge no prior study has investigated the effects of CBASP versus a nonspecific 
therapy, here SP, on the alliance over such a long observation period and with data 
from every single session. Furthermore, the novelty of Study 2 lies in the 
consideration of the impact of CM on the alliance during treatment with CBASP and 
SP. Subdividing the patient sample into tertiles with low, medium and high CM poses 
a further advantage. It allowed for the comparison of patients with discriminative 
degrees of CM. This resulted in a richer picture than the one achieved if we had 
relied on a dichotomous division of patient groups with versus without CM as done 
elsewhere (e.g., Bausch et al., 2017; Klein et al., 2018).  
 In synopsis of the studies’ results, their limitations and strengths, one can 
conclude that the German HAQ, its versions for patients and therapist, offer 
sufficiently reliable measurement instruments. The HAQ may be used 
unidimensionally to assess the global alliance or two-dimensionally to measure the 
subscales ‘relation to the therapist/patient’ and ‘satisfaction with therapeutic 
outcome’. These findings are relevant to psychotherapy research as the HAQ is a 
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very frequently applied instrument, especially in the German speaking countries 
(Elvins & Green, 2008; Nübling et al., 2017; Wampold & Imel, 2015). Yet, the HAQ 
presents psychometric shortcomings which suggest that future research may seek to 
improve on the HAQ or aim at establishing alternative instruments. Potentially, the 
HAQ-II by Luborsky et al. (1996), a revised version of the HAQ, devoid of outcome-
related items and enriched by additional items on the relationship aspect of the 
alliance, may be translated into German and subsequently examined. Arguably, a 
new instrument could only replace the HAQ with all its advantages, for example, 
economic usability, widespread application in the scientific literature, when the 
superiority of the new assessment tool in terms of psychometrics has firmly been 
established. 
 The results from Study 2 suggest that CBASP is more effective than SP in 
creating a positive therapeutic alliance with persistently depressed patients in 
general. CBASP and SP fare comparably well regarding the alliance with patients 
who have experienced low or medium degrees of CM. In the subgroup of patients 
with a history of severe CM, CBASP has a superior effect on the increase of alliance 
ratings, which is particularly pronounced on the subscale ‘satisfaction with 
therapeutic outcome’. 
 Future research may expand the analyses by taking into account that patient 
data was nested by therapists. That approach would allow investigating to what 
degree therapist effects explain variance in the data. Del Re et al. (2012), for 
instance, found that the ratio of patients to therapist significantly moderates the 
relationship between alliance and treatment outcome. Hence, future studies, which 
aim at disentangling the relationship between alliance and treatment outcome, here 
for example, HRSD scores, in persistently depressed patients, may want to examine 
therapist-related moderators.  
In order to achieve a more comprehensive understanding of the alliance in the 
treatment of persistent depression, future research should study the alliance from the 
therapist’s perspective, too. To this end, one could firstly answer the question if the 
findings from Study 2 are paralleled by the therapists’ HAQ ratings. Further studies 
could then approach patients’ and therapists’ evaluations from a dyadic stance as 
was recently done by Laws et al. (2017). The authors tested if discrepancy or 
divergence in alliance ratings by persistently depressed patients and their therapists 
predicted therapy outcome. Results indicated that patients’ and therapists’ ratings 
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converged over time, which was associated with some outcome measures. The 
alliance data from the superordinate RCT by Schramm et al. (2011a), which this 
dissertation relied on, was collected at sessions over a longer treatment period than 
in the study by Laws et al. (2017). Hence, applying this methodology (Laws et al., 
2017) to the herein employed data may provide a more detailed understanding. 
 From the methodological approach in this dissertation, one cannot deduct 
which specific techniques in CBASP lead to overall higher mean ratings and to a 
stronger increase in alliance ratings in the subgroup of high CM patients over time. 
Future process research should seek to disseminate how CBASP effects alliance.  
Testing different mediational models could further analyse how the 
incremental increase in alliance ratings came about. Constantino et al. (2016), for 
example, found support for an explanatory model in which CBASP lead to improved 
alliance, which resulted in a decrease in patient hostile-submissiveness and in better 
therapy outcome (Constantino et al., 2016). One could test whether the increase in 
alliance ratings (early versus late alliance) is mediated by patients’ interpersonal 
change. And whether to this effect there are differences between patients with 
distinct levels of CM. If in CBASP the link between early and late alliance ratings is 
mediated by interpersonal change this would explain the pronounced increase in 
alliance ratings, especially on the subscale ‘satisfaction with outcome’ in the 
subgroup of patients with high CM.  
 Results from Study 2 support the notion by Klein et al. (2018) that higher CM 
may serve as a differential indicator for treatment with CBASP. Future research on 
adverse side effects is needed to further elucidate CBASP’s contraindications. More 
particularly, further studies should examine the possible side effects considering that 
there may be differences depending on the degree of CM experienced by patients. 
Analyses on positive and negative effects of CBASP, in patients with different 
characteristics, for instance, history of CM, may then inform practitioners on when to 
apply or refrain from CBASP  
 One can conclude that the instrument used in this dissertation to assess the 
alliance between persistently depressed patients and their therapists, that is, the 
HAQ, exhibits acceptable psychometric properties. The thereby assessed patient 
rated alliance improved over the course of a 48-week long treatment with CBASP 
and SP, respectively. On average, CBASP was more effective than SP in creating a 
positive therapeutic alliance across treatment. Moreover, CBASP has a more positive 
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effect on the increase of alliance in the subgroup of patients with a history of high 
CM, which was particularly pronounced on the subscale ‘satisfaction with therapeutic 
outcome’. Several follow-up issues remain open to future research. Among other, 
these include questions on therapist effects, the outcome-alliance link and process-
research on how CBASP achieves superior change in the subgroup of patients who 
have experienced severe maltreatment growing up. 
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8 SUMMARY 
The present dissertation investigated the impact of childhood maltreatment (CM) and 
the differential effects of the disorder-specific Cognitive Behavioral Analysis System 
of Psychotherapy (CBASP) and nonspecific Supportive Psychotherapy (SP) on the 
alliance. The alliance was assessed by the German Helping Alliance Questionnaire 
(HAQ), whose psychometric quality was examined for that purpose. Analyses relied 
on data from a randomized-controlled clinical trial which compared CBASP to SP in 
the treatment of 268 early-onset persistently depressed outpatients. Both treatments 
ran in parallel and consisted of 32 individual sessions over the course of 48 weeks. 
The first study explored the psychometrics of the German HAQ for patients 
(HAQ-P) and therapists (HAQ-T). Results indicated that the HAQ is internally 
consistent and may be used unidimensionally to assess a global helping alliance or 
two-dimensionally to examine the two subscales ‘relation to the patient/therapist’ and 
the ‘satisfaction with therapeutic outcome’. Analyses on convergent validity to a 
measure of interpersonal problems found small significant correlations. The second 
study investigated how both dimensions of the alliance developed over time, if 
CBASP had a superior effect on the mean alliance ratings, and whether there were 
differential effects of CBASP and SP on the course of alliance between patients with 
low versus medium versus high CM. Findings indicated an improvement of alliance in 
both treatments and that CBASP led to more positive overall mean alliance ratings. 
Only in the group of patients with high CM did CBASP have a distinctly more positive 
effect on the increase in alliance ratings: Patients with high CM receiving CBASP 
rated the alliance increasingly more favourable than patients who received SP. This 
effect was more pronounced on the subscale ‘satisfaction with therapeutic outcome’. 
Together, the two studies demonstrated that the German HAQ provides an 
adequate instrument for the uni- and two-dimensional measurement of the alliance. 
Patients perceived the alliance, as assessed by the HAQ-P, increasingly positive 
over the course of both CBASP and SP. In comparison to the nonspecific treatment, 
there appears to be an overall positive effect of CBASP on both dimensions of the 
alliance, that is, ‘relation to therapist’ and ‘satisfaction with therapeutic outcome’. Only 
in the group of patients with high CM, did CBASP have a more favourable effect on 
the increase in alliance ratings, which was particularly large on the ‘satisfaction with 
therapeutic outcome’. 
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